Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1050.Time spend outdoors in summer,50347,0.0374226798653059,0.0335916154910301,-0.028416886497113,0.103262246227725,0.265271153906104
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1060.Time spent outdoors in winter,48193,0.0591227483957132,0.0371445525158841,-0.0136805745354196,0.131926071326846,0.111470193335632
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X1070.Time spent watching television (TV),51566,-0.116837611970216,0.0340768834488661,-0.183628303529994,-0.050046920410439,0.000607690280905305
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X1080.Time spent using computer,48254,0.0598896361320729,0.0333452345135953,-0.00546702351457387,0.12524629577872,0.072502742296125
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X1090.Time spent driving,44015,0.0128750231289945,0.0383822487771545,-0.0623541844742283,0.0881042307322174,0.737296342985903
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1160.Sleep duration,52369,0.0461405642918929,0.0297264096405634,-0.0121231986036114,0.104404327187397,0.120634217867517
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,35673,0.0250583583966901,0.0167569380938847,-0.00778524026732391,0.0579019570607042,0.134858268278337
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,35673,-0.0318691879321709,0.0160203842732625,-0.0632691411077654,-0.000469234756576432,0.0467111976405902
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,35673,-0.0303766603347849,0.0175434394461187,-0.0647618016491776,0.00400848097960785,0.0834082460773491
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,35673,-0.021586554023637,0.017599155923906,-0.0560808996344927,0.0129077915872187,0.220029734864162
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,35673,0.00130528696166865,0.0176155877934232,-0.0332212651134409,0.0358318390367782,0.940934371747397
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,35673,-0.0137081635443062,0.0441693623921455,-0.100280113832911,0.0728637867442989,0.756301318807089
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,35673,-0.022495657132224,0.0467404891557004,-0.114107015877397,0.0691157016129488,0.630327765188782
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,35673,0.0151875648420647,0.0301289489040849,-0.0438651750099418,0.0742403046940712,0.614218469650744
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,35673,-0.0520689012899788,0.0219032983055455,-0.094999365968848,-0.00913843661110959,0.0174726668427437
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,35673,-0.0165249635490357,0.0143369364791222,-0.0446253590481152,0.0115754319500437,0.249111096260325
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#18.Location of pain during the past week_Upper back,35673,-0.0248820806357261,0.0214874062413643,-0.0669973968688002,0.017233235597348,0.246913097904803
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#19.Location of pain during the past week_Lower back,35673,-0.0124617929751785,0.0115923156975273,-0.0351827317423319,0.010259145791975,0.282412689281349
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,35673,-0.00307371144348179,0.0151533276251544,-0.0327742335887845,0.0266268107018209,0.839265921674174
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,35673,-0.0492844750960661,0.0217141698938215,-0.0918442480879562,-0.00672470210417603,0.0232590014953439
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,35673,-0.0258276753323104,0.0203438312051105,-0.0657015844943269,0.0140462338297062,0.204287687224438
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,35673,-0.0254893263705919,0.031342957605512,-0.0869215232773955,0.0359428705362116,0.416110727557292
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,35673,0.0244750115187041,0.0298773263707971,-0.0340845481680583,0.0830345712054665,0.412711882471001
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#7.Location of pain during the past week_Left hip,35673,-0.0216476606486515,0.0157544933825307,-0.0525264676784117,0.00923114638110869,0.169469770532184
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#8.Location of pain during the past week_Right hip,35673,-0.0292531695983497,0.0148799989833722,-0.0584179676057592,-8.83715909402484e-05,0.0493483001127498
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,35673,-0.0313912023248661,0.018962805996647,-0.0685583020782943,0.00577589742856199,0.0978899644769678
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120040.Fatigue severity over the past week,35677,-0.0885130083613768,0.0591748391040706,-0.204495693005355,0.0274696762826017,0.134757626146012
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120041.Waking unrefreshed severity over the past week,35675,-0.0141454590175938,0.0590259010086036,-0.129836224994457,0.101545306959269,0.810610469801618
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120042.Cognitive symptoms severity over the past week,35677,-0.0523457336085019,0.063026787822255,-0.175878237740122,0.0711867705231179,0.406268930219523
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120098.Mobility problems today,35681,-0.168380203625803,0.0649293980546681,-0.295641823812953,-0.041118583438654,0.00952785638637781
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120099.Self-care problems today,35681,-0.433752811355863,0.099377917109246,-0.628533528889985,-0.238972093821741,1.29285397072207e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120100.Problems doing usual activities,35681,-0.172741131435803,0.0630796277093342,-0.296377201746098,-0.0491050611255083,0.00618959542697904
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120101.Pain or discomfort today,35681,-0.0982038098059576,0.0586781427711393,-0.213212969637391,0.0168053500254755,0.0942572383555398
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120102.Anxiety or depression today,35681,-0.113630790555181,0.0743922146917284,-0.259439531350969,0.0321779502406062,0.126696584664978
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120103.Scale to indicate how health is today,35659,0.00968900895487201,0.00507231893477832,-0.000252736157293508,0.0196307540670375,0.0561550844685146
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,35656,-0.00905129126642998,0.0758746718361694,-0.157765648065322,0.139663065532462,0.905047209518186
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",35646,-0.082323842076938,0.079146859745146,-0.237451687177424,0.0728040030235482,0.298313688847902
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",35662,-0.0495361264128022,0.0595702502605765,-0.166293816923532,0.0672215640979277,0.405689106088185
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,35661,-0.0674948521262343,0.0609013627300205,-0.186861523077074,0.0518718188246059,0.26778859029662
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,35672,-0.104347153177127,0.0876773707800457,-0.276194799906017,0.0675004935517621,0.234040343945042
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120109.Feeling bad about self over the last two weeks,35651,-0.06113357810351,0.0855355495314384,-0.228783255185129,0.106516098978109,0.474810739824813
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120110.Trouble concentrating over the last two weeks,35665,-0.0495266701182393,0.0846897688700808,-0.215518617103598,0.116465276867119,0.558701858815643
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,35664,-0.252269536401565,0.1161721119259,-0.479966875776328,-0.024572197026801,0.0299284576181797
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,35643,0.00344040259885559,0.176705890796931,-0.34290314336313,0.349783948560841,0.984467047344929
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33493,-0.109988287429718,0.0832618242005094,-0.273181462862717,0.0532048880032802,0.186574037214246
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1269.Exposure to tobacco smoke at home,50555,-0.0874490327167355,0.0744459446325503,-0.233363084196534,0.0584650187630631,0.240141931260893
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,48742,-0.0694491029779576,0.0461172268491757,-0.159838867602342,0.0209406616464267,0.132102485747982
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1289.Cooked vegetable intake,51913,-0.0495594069077485,0.0315776266850913,-0.111451555210527,0.0123327413950303,0.116557780474087
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1299.Salad  or  raw vegetable intake,51102,0.00323360183859271,0.0328400186481882,-0.0611328347118562,0.0676000383890416,0.92156373635841
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1309.Fresh fruit intake,51834,-0.0715631651850578,0.0323567451150172,-0.134982385610491,-0.00814394475962421,0.0269978800554111
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1319.Dried fruit intake,50618,-0.00690198117465815,0.0325198634278457,-0.0706409134932357,0.0568369511439194,0.831922652157869
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X134.Number of self-reported cancers,52580,-0.0264605551477653,0.0500473047683944,-0.124553272493818,0.0716321621982876,0.59701103837579
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X135.Number of self-reported non-cancer illnesses,52581,-0.328092484172544,0.032732212471794,-0.39224762061726,-0.263937347727828,1.34060515801579e-23
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X136.Number of operations, self-reported",52581,-0.0541774519454225,0.0313767522266274,-0.115675886309612,0.00732098241876716,0.0842392635859377
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X137.Number of treatments or medications taken,52581,-0.354802922112422,0.0313362843712698,-0.416222039480111,-0.293383804744733,1.21383568835498e-29
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1438.Bread intake,51946,0.00242710974104552,0.00289282944525039,-0.00324283597164524,0.00809705545373629,0.40147311271638
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1458.Cereal intake,51596,-0.0489851008166297,0.0311003094645621,-0.109941707367171,0.011971505733912,0.115254881552083
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1488.Tea intake,51871,-0.0136808120679489,0.00280228661433795,-0.0191732938320513,-0.00818833030384655,1.05719828411425e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1498.Coffee intake,50871,-0.17743533526884,0.0312489956473504,-0.238683366737647,-0.116187303800034,1.37930692268037e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1528.Water intake,50685,0.000753061028396586,0.0313120600274454,-0.0606185766253965,0.0621246986821897,0.980812796832739
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1568.Average weekly red wine intake,45156,0.077617363558763,0.0360116994618391,0.00703443261355831,0.148200294503968,0.0311503434202003
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,45153,0.0829732702507167,0.0369570735897727,0.0105374060147622,0.155409134486671,0.0247737102321684
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1588.Average weekly beer plus cider intake,45201,0.0634279160714562,0.0416605878240047,-0.018226836063593,0.145082668206505,0.127905577053375
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1598.Average weekly spirits intake,45137,-0.00209241585113172,0.0388843741959796,-0.0783057892752517,0.0741209575729883,0.957086239625307
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1608.Average weekly fortified wine intake,45185,-0.0266392330519752,0.058561632255208,-0.141420032272183,0.0881415661682326,0.649192929562275
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1737.Childhood sunburn occasions,46180,-0.00522327827885789,0.0379753920930572,-0.07965504678125,0.0692084902235343,0.890602634975982
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X1807.Father's age at death,50426,0.00421450869987083,0.00271767283309992,-0.00111213005300501,0.00954114745274668,0.120969670485012
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X1845.Mother's age,32639,0.0054597629090571,0.0122693309322015,-0.0185881257180579,0.0295076515361721,0.656352974160239
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X1873.Number of full brothers,52151,-0.00538228522970068,0.0299150806304792,-0.0640158432654398,0.0532512728060385,0.857217908531672
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X1883.Number of full sisters,52159,-0.0158611371790744,0.0300111202457632,-0.0746829328607702,0.0429606585026215,0.59715144013904
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X20015.Sitting height,52409,0.0352895612198373,0.00361565944750637,0.0282028687027248,0.0423762537369498,1.8427732573499e-22
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20016.Fluid intelligence score,36833,0.0824940260892863,0.0482011120050691,-0.0119801534406491,0.176968205619222,0.0870378397569587
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20018.Prospective memory result,37197,-0.0496344337857278,0.0590650573937608,-0.165401946277499,0.0661330787060433,0.400745701538762
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),36707,-0.00516689105147183,0.004991394465732,-0.0149500242043066,0.0046162421013629,0.300627592010624
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),36693,-0.00799940916592963,0.00500321793078772,-0.0178057163102736,0.0018068979784143,0.109895435178355
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20023.Mean time to correctly identify matches,52270,-0.00995582738015183,0.00295842764870668,-0.0157543455716169,-0.00415730918868674,0.000766009419033065
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#1.Illnesses of father_Heart disease,49103,0.00187547515864709,0.00613560762331205,-0.0101503157830445,0.0139012661003387,0.759858619555161
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48648,0.0137214576411718,0.0130270885593791,-0.0118116359352112,0.0392545512175547,0.292215712440647
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48613,-0.00391166737924705,0.0173618095141606,-0.0379408140270017,0.0301174792685076,0.821745954285125
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#12.Illnesses of father_Severe depression,48621,0.0231443697680678,0.0166721670056852,-0.00953307756307514,0.0558218170992108,0.165090837459251
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48644,-0.00656853560342197,0.0115515770583397,-0.0292096266377678,0.0160725554309239,0.569616039324984
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#2.Illnesses of father_Stroke,48822,0.00498591625210696,0.00770415513482743,-0.0101142278121548,0.0200860603163687,0.517527966926144
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48764,-0.0131786454169418,0.00942720217637733,-0.0316559616826414,0.00529867084875774,0.162147489891249
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48665,-0.00257088249199619,0.0122009305100777,-0.0264847062917485,0.0213429413077561,0.833114213735733
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48817,-0.0184812186864889,0.00833946337151677,-0.0348265668946618,-0.00213587047831606,0.0266949825032692
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48810,0.0106784800773271,0.00771020920869045,-0.00443352997170624,0.0257904901263603,0.166074550447002
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#9.Illnesses of father_Diabetes,48687,0.00908110841503428,0.0110023727880677,-0.0124835422495784,0.0306457590796469,0.409167536034751
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#1.Illnesses of mother_Heart disease,50228,-0.00317955162133024,0.00669799446263847,-0.0163076207681017,0.00994851752544117,0.635004293529029
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,50064,0.0112686791131899,0.00872249740641279,-0.00582741580337916,0.028364774029759,0.196402719749383
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49972,0.00832404436837998,0.0194937638389466,-0.0298837327559554,0.0465318214927154,0.669376010022207
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49998,-0.0140916755245337,0.0121347019440829,-0.0378756913349362,0.00969234028586875,0.245545097714477
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#2.Illnesses of mother_Stroke,50159,-0.00256916551722767,0.00735236758875334,-0.0169798059911842,0.0118414749567289,0.726767194875721
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,50019,0.00487829482035393,0.0140859470293454,-0.022730161357163,0.0324867509978709,0.729103090129695
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,50005,-0.00577463987845447,0.0118648876923002,-0.0290298197553628,0.0174805399984539,0.626476128142291
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,50007,-0.00307508054315769,0.0104568076085846,-0.0235704234559835,0.0174202623696681,0.768703902974857
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,50056,0.0120478500361239,0.0117324752970413,-0.010947801546077,0.0350435016183248,0.304488645939327
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,50206,0.00317039882334433,0.00653013269182734,-0.00962866125263726,0.0159694588993259,0.627324667816332
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#9.Illnesses of mother_Diabetes,50069,-0.0203330773086757,0.00997098709111353,-0.0398762120072582,-0.000789942610093144,0.0414402330737858
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46365,-0.0255434850945755,0.00848437565340541,-0.0421728613752501,-0.0089141088139009,0.00261068041596524
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46187,0.0295645624677879,0.0295516939417643,-0.0283567576580702,0.087485882593646,0.317114062922402
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46178,0.0544197233696171,0.0313239360469748,-0.00697519128245357,0.115814638021688,0.0823487028313491
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46210,0.00440055449740953,0.012908530251599,-0.0209001647957244,0.0297012737905435,0.733180942898925
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46203,0.000603572064270758,0.0176478863940371,-0.033986285268042,0.0351934293965835,0.972717419474819
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46239,-0.0580575566855081,0.0141303718830817,-0.0857530855763483,-0.0303620277946679,3.99739969877489e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46202,-0.0478174785276915,0.0157461216523411,-0.0786798769662802,-0.0169550800891029,0.0023948345004761
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46196,-0.00368645487008344,0.0159074572803019,-0.0348650711394752,0.0274921613993083,0.816739785502473
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46217,-0.00711773653182716,0.0129783968301803,-0.0325553943189806,0.0183199212553262,0.583404172326846
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46232,-0.0142826486170088,0.0153279419258736,-0.0443254147917211,0.0157601175577034,0.351450658644085
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46412,-0.00827800469876335,0.00713394229984949,-0.0222605316064683,0.00570452220894164,0.245914736513077
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46300,-0.0454078382265331,0.00981393741877727,-0.0646431555673366,-0.0261725208857297,3.73951247926657e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20127.Neuroticism score,47560,-0.04827968660693,0.0315586392553213,-0.11013461954736,0.0135752463334997,0.126073429923192
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,36833,0.0199698090473621,0.0487991582814308,-0.0756765411842423,0.115616159278967,0.68238643740843
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X20161.Pack years of smoking,37102,-0.0173548539240882,0.00488330781119084,-0.0269261372340223,-0.00778357061415417,0.000381757781952441
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,37102,-0.0179366920329015,0.00504589656746025,-0.0278266493051236,-0.00804673476067945,0.000380607214574741
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20191.Fluid intelligence score,34390,0.11087138637524,0.0603875501250544,-0.00748821186986635,0.229230984620347,0.0664152766475587
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34391,0.0497636619824205,0.0612870168869557,-0.0703588911160127,0.169886215080854,0.416841974261122
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20240.Maximum digits remembered correctly,33737,0.00145775569209152,0.0658429945269543,-0.127594513580739,0.130510024964922,0.982337352356371
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X20255.Spirometry QC measure,46459,0.00649748637261095,0.0402195330351392,-0.0723327983762618,0.0853277711214837,0.871661716802208
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X20261.avMSE,34400,-0.00349725916289923,0.0056096116168587,-0.0144920979319423,0.00749757960614382,0.53302239223609
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X20262.Myopia diagnosis,34400,0.00144760469569093,0.0764812506556925,-0.148455646589466,0.151350855980848,0.984899606367606
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X20280.Glucose-lactate,42722,-0.0171598914553151,0.00359480363127316,-0.0242057065726105,-0.0101140763380197,1.82922254644166e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X20281.Spectrometer-corrected alanine,42748,0.000958241067457656,0.00368544656895517,-0.00626523420769448,0.00818171634260979,0.794862498880013
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,36515,-0.000763261434340761,0.022694716869367,-0.0452449064983001,0.0437183836296186,0.973171777151262
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,36515,0.075789300539426,0.0429627881674993,-0.00841776426887252,0.159996365347725,0.0777621489706992
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),36515,0.122048811956149,0.0713363719761027,-0.0177704771170123,0.26186810102931,0.0871434564439398
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),36515,0.00952728974704755,0.0208298958079022,-0.0312993060364408,0.0503538855305359,0.647407645347387
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),36515,0.00264800275171696,0.0433749528971957,-0.0823669049267866,0.0876629104302205,0.95132175544006
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,36518,-0.0284138878191556,0.0548310849816984,-0.135882814383284,0.0790550387449733,0.604329050020722
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,36518,0.0114126002750114,0.0337800476571357,-0.0547962931329745,0.0776214936829974,0.735485661961185
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,36518,0.0152481708294234,0.0407955082877363,-0.0647110254145397,0.0952073670733865,0.70858564531293
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,36518,-0.0809283871128335,0.0632066891178683,-0.204813497783855,0.0429567235581884,0.200453148539554
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,36518,-0.0617712100269125,0.073556562583504,-0.20594207269058,0.0823996526367554,0.401060075997298
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,36518,0.050931453763354,0.0446468208570965,-0.0365763151165551,0.138439222643263,0.254005745574515
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,36518,-0.00537511723397428,0.076023839065915,-0.154381841803168,0.143631607335219,0.943636024380022
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,36518,-0.0712764833614064,0.0525681901215693,-0.174310135999682,0.0317571692768693,0.175177183152909
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),36517,0.0896374391797877,0.0723751844847569,-0.0522179224103359,0.231492800769911,0.21556646252967
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),36517,0.006328928111084,0.0283266509501816,-0.0491913077512719,0.0618491639734399,0.823209713842393
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),36517,-0.00842922992520497,0.0521602965781021,-0.110663411218285,0.0938049513678751,0.871623413119131
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,36519,-0.0186823749994973,0.0893861322255181,-0.193879194161513,0.156514444162518,0.834448169632788
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20600.Liking for adding salt to foods,36327,0.0499737619368044,0.052398083267968,-0.0527264812684129,0.152674005142022,0.340251356012413
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20601.Liking for aniseed,36327,-0.0426852481492001,0.052244650952047,-0.145084764015212,0.059714267716812,0.413940782172344
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20602.Liking for apple juice,36327,0.143344117237803,0.0523013910544462,0.0408333907710883,0.245854843704517,0.00614552234786078
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20603.Liking for apples,36327,0.0121653515665881,0.0535011136340296,-0.09269683115611,0.117027534289286,0.82013089578288
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20604.Liking for asparagus,36327,0.0195945788580589,0.0530472331563388,-0.084377998128365,0.123567155844483,0.71185559585345
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20605.Liking for aubergine,36327,0.0172105791510969,0.0524372277021685,-0.0855663871451533,0.119987545447347,0.742760274720155
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20606.Liking for avocados,36327,0.0612929940668662,0.0529994732165888,-0.0425859734376479,0.16517196157138,0.247522395249288
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20607.Liking for bacon,36327,-0.0185537546108829,0.0527889579164107,-0.122020112127048,0.0849126029052821,0.725245891419291
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20608.Liking for baked or steamed fish,36327,-0.0129336439355616,0.0531669901304468,-0.117140944591237,0.0912736567201142,0.807807468516495
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20609.Liking for bananas,36327,-0.0260563574809351,0.0542726310652153,-0.132430714368757,0.0803179994068868,0.631170146819059
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36327,0.0370230448992688,0.0522345899666163,-0.0653567514352991,0.139402841233837,0.478481681683596
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20611.Liking for beef steak,36327,-0.0165959928666355,0.0527993677715936,-0.120082753698959,0.086890767965688,0.753285838951894
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20612.Liking for beetroot,36327,-0.0686185127037321,0.0533438363327023,-0.173172431915829,0.0359354065083644,0.198364907828507
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20613.Liking for bell pepper,36327,0.00964676039194002,0.0521423473122424,-0.0925522403400551,0.111845761123935,0.853227891926578
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20614.Liking for bicycling,36327,0.194664268412007,0.0524041272398195,0.091952179021961,0.297376357802054,0.000205021646060257
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20615.Liking for biscuits,36327,0.0480249558282588,0.0522469675949168,-0.054379100657778,0.150429012314296,0.35802666424541
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20616.Liking for bitter foods,36327,-0.0175191381959344,0.0524634191491983,-0.120347439728363,0.0853091633364944,0.738441798107578
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20617.Liking for bitter or ale,36327,0.0639724544367986,0.053344426916772,-0.0405826223200744,0.168527531193672,0.230476826651683
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20618.Liking for black olives,36327,0.0255016436091047,0.0527312824101747,-0.0778516699148376,0.128854957133047,0.628673931129358
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20619.Liking for black pepper,36327,0.0270835713239567,0.0531943997014055,-0.0771774520907982,0.131344594738712,0.610667563435574
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20620.Liking for blue cheese,36327,-0.0901932551742978,0.0527706371406543,-0.19362370396998,0.0132371936213847,0.0874655959110662
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20621.Liking for bolognese sauce,36327,-0.00531185214841433,0.0524507421611602,-0.108115306784288,0.0974916024874597,0.919336475717813
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20622.Liking for broad beans,36327,-0.0528268733862954,0.0521179283937783,-0.154978013038101,0.0493242662655101,0.310806787887733
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20623.Liking for broccoli,36327,-0.0863447748713506,0.0537011502487097,-0.191599029358821,0.0189094796161204,0.107906717326192
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20624.Liking for brown rice,36327,-0.00220027606151725,0.0527638602533788,-0.10561744215814,0.101216890035105,0.966738673720103
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20625.Liking for brussel sprouts,36327,-0.108583102506892,0.0526934494920709,-0.211862263511351,-0.00530394150243305,0.0393720390622872
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20626.Liking for burgers (meat),36327,-0.123840842694486,0.0519540881448656,-0.225670855458423,-0.0220108299305498,0.0171675045168716
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20627.Liking for burn of spicy foods,36327,-0.00881509172879822,0.0521970191093868,-0.111121249183196,0.0934910657255999,0.865894934244784
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20628.Liking for butter on bread,36327,0.0699480329265635,0.0528725740415111,-0.0336822121947983,0.173578278047925,0.18589282545999
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20629.Liking for butternut squash,36327,-0.0966536151863544,0.0521954881529872,-0.198956771966209,0.00564954159350051,0.0641013722792756
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20630.Liking for cabbage,36327,-0.00755438867904594,0.0532305262655952,-0.111886220159613,0.0967774428015207,0.887148509569412
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20631.Liking for cake,36327,0.0610027060176121,0.052781505219721,-0.042449044213041,0.164454456248265,0.247818458140888
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20632.Liking for cake icing,36327,0.0105134528026446,0.0526367863656056,-0.0926546484739423,0.113681554079231,0.841692882048429
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20633.Liking for capers,36327,0.0502496518381852,0.0520126318330553,-0.0516951065546032,0.152194410230974,0.334024551282756
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20634.Liking for cauliflower,36327,-0.134553291905136,0.0534136970235102,-0.239244138071216,-0.0298624457390559,0.0117879528763846
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20635.Liking for cereal or granola bar,36327,0.112836561758652,0.0522779323239433,0.0103718144037235,0.215301309113581,0.0309302346237821
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20636.Liking for cheesecake,36327,-0.0178877390455483,0.0525288088573523,-0.120844204405959,0.0850687263148622,0.733465988099035
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20637.Liking for cherries,36327,-0.0230165916734158,0.0558425270286411,-0.132467944649552,0.0864347613027208,0.680227523675902
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20638.Liking for chicken,36327,-0.0154109742122828,0.0551749010960434,-0.123553780360528,0.0927318319359622,0.780014031273062
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20639.Liking for chilli pepper,36327,-0.00576488725810565,0.0525735456475766,-0.108809036727356,0.0972792622111445,0.912687057349474
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20640.Liking for chips or french fries,36327,0.0984961552161156,0.0527738418443732,-0.00494057479885579,0.201932885231087,0.0620289769816627
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20641.Liking for cigarette smoking,36327,-0.126940025353413,0.0880864182942604,-0.299589405210163,0.0457093545033377,0.149604591700751
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20642.Liking for cod,36327,-0.0983001722942988,0.0541638530898205,-0.204461324350347,0.0078609797617494,0.0695864355450197
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20643.Liking for coffee with sugar,36327,0.0201875844881865,0.0571082476150964,-0.0917445808374025,0.132119749813775,0.723726465096649
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20644.Liking for coffee without sugar,36327,-0.158906971211177,0.0535546611091243,-0.26387410698506,-0.0539398354372931,0.00301531853812968
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20645.Liking for coriander,36327,-0.0223864701873742,0.052533871155017,-0.125352857651208,0.0805799172764592,0.670023059666049
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20646.Liking for corn flakes,36327,-0.0407796334294728,0.0523584217382139,-0.143402140036372,0.0618428731774265,0.436090836775199
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20647.Liking for cream,36327,-0.00517200858553323,0.0524363807117083,-0.107947314780482,0.0976032976094151,0.92143166960957
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20648.Liking for croissant,36327,-0.0279643434330033,0.0523439344649902,-0.130558454984384,0.0746297681183774,0.593190584135649
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20649.Liking for cucumber,36327,-0.0345990572191776,0.052529007302887,-0.137555911532836,0.0683577970944809,0.510131727181218
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20650.Liking for curry,36327,0.000500525231529798,0.0525143381460957,-0.102427577534818,0.103428627997877,0.992395576006903
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20651.Liking for dairy products,36327,0.0423972174947212,0.0531869831951551,-0.0618492695677829,0.146643704557225,0.425399070018382
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20652.Liking for dark chocolate,36327,-0.124444291494066,0.0530455721256538,-0.228413612860348,-0.0204749701277848,0.0190039701211956
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20653.Liking for diet fizzy drinks,36327,-0.110857084696449,0.0545824084842381,-0.217838605325556,-0.00387556406734264,0.04229165518015
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20654.Liking for dried fruit,36327,-0.0755106090800276,0.0530030963601997,-0.179396677946019,0.0283754597859638,0.154303578632815
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20655.Liking for eggs,36327,-0.0592868273882677,0.0538108905346007,-0.164756172836085,0.0461825180595498,0.27060210924919
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20656.Liking for exercising alone,36327,0.094298236567544,0.052744005581318,-0.00908001437183936,0.197676487506927,0.0738431101783259
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20657.Liking for exercising with others,36327,0.0753252429839718,0.0527037356175747,-0.0279740788264747,0.178624564794418,0.152984803319924
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20658.Liking for extra virgin olive oil,36327,-0.0140988481293259,0.0527211093096583,-0.117432222376256,0.0892345261176044,0.789151074608426
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20659.Liking for fatty foods,36327,0.000450347253685324,0.0522131296910841,-0.101887386940839,0.10278808144821,0.993118434812733
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20660.Liking for fresh tomatoes,36327,-0.119340233702828,0.0565739549428578,-0.23022518539083,-0.00845528201482718,0.0349400864625243
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20661.Liking for fried chicken,36327,-0.0261118991756622,0.0519574214816736,-0.127948445279742,0.0757246469284181,0.61528679097225
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20662.Liking for fried or battered fish,36327,0.0328057785888376,0.0529389628583669,-0.0709545886135615,0.136566145791237,0.535481312547537
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20663.Liking for fruit,36327,-0.0023201092062064,0.0597821330258529,-0.119493089936878,0.114852871524465,0.96904343125121
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20664.Liking for garlic,36327,0.0216996424332357,0.052953687809388,-0.0820895856731648,0.125488870539636,0.681975777458808
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20665.Liking for gherkins,36327,-0.0990927832259497,0.0524896025239917,-0.201972404172974,0.00378683772107409,0.0590859604047782
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20666.Liking for globe artichoke,36327,0.0139524025188696,0.0529869719322677,-0.089902062468375,0.117806867506114,0.792313407199362
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20667.Liking for goat's cheese,36327,0.0198161136624057,0.0521055102738867,-0.0823106864744122,0.121942913799224,0.703728545265853
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20668.Liking for going to a cafe,36327,-0.0388211372576762,0.0524076532616831,-0.141540137650575,0.0638978631352226,0.458867505376665
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20669.Liking for going to the gym,36327,0.0518299082001373,0.0526249091868004,-0.0513149138059915,0.154974730206266,0.324710046806004
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20670.Liking for going to the pub,36327,0.0980426181758551,0.0523737222966649,-0.00460987752560807,0.200695113877318,0.0612501585196564
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20671.Liking for grapefruit,36327,0.106487529025572,0.0520120559385779,0.0045438993859592,0.208431158665185,0.0406591127714926
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20672.Liking for green olives,36327,0.0500358891648424,0.0523567446608122,-0.0525833303703495,0.152655108700034,0.339270262562167
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20673.Liking for haddock,36327,-0.0963291755964354,0.0540465430531433,-0.202260399980596,0.00960204878772548,0.0747368018793446
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20674.Liking for ham,36327,0.0419338684803174,0.05260444261936,-0.0611708390536282,0.145038576014263,0.425387870537663
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20675.Liking for hard cheese,36327,-0.0488547450202179,0.0535195998982176,-0.153753160820724,0.0560436707802885,0.361358438246345
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20676.Liking for herring,36327,-0.0624475667012661,0.0522377025431085,-0.164833463685759,0.0399383302832266,0.231951013138945
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20677.Liking for honey,36327,0.0626574952630223,0.0524507043608814,-0.0401458852843053,0.16546087581035,0.23228398536658
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20678.Liking for horseradish or wasabi,36327,0.0420951407716785,0.0521357528081388,-0.0600909347322735,0.14428121627563,0.419454915585166
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20679.Liking for ice cream,36327,-0.0557661166223797,0.0528900093203719,-0.159430534890309,0.0478983016455493,0.291745177441035
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20680.Liking for jam,36327,0.0279170494862468,0.0521984183846664,-0.0743918505476993,0.130225949520193,0.592787163302316
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20681.Liking for kiwi fruit,36327,-0.000170296512279715,0.052324717544323,-0.102726742899153,0.102386149874593,0.997403293200972
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20682.Liking for lager,36327,0.0122653154455839,0.0527061085258016,-0.0910386572649872,0.115569288156155,0.815992155156284
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20683.Liking for lamb,36327,-0.0929630386565363,0.0532997500311468,-0.197430548717584,0.0115044714045114,0.0811751515895447
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20684.Liking for lemons,36327,0.0238344629213328,0.0527837909806842,-0.0796217674008083,0.127290693243474,0.651607733117136
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20685.Liking for lentils or beans,36327,0.0801688541224034,0.0530539580890459,-0.0238169037321267,0.184154611976933,0.13081204285723
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20686.Liking for liver,36327,-0.0556802637446218,0.0524042162419335,-0.158392527578811,0.0470320000895679,0.288037985787127
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20687.Liking for mackerel,36327,-0.0210192090842737,0.0526483239296997,-0.124209923986485,0.0821715058179378,0.689729847800635
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20688.Liking for marzipan,36327,-0.0801108317114352,0.0523314419741142,-0.182680457980699,0.0224587945578286,0.125854442450546
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20689.Liking for mayonnaise,36327,-0.00855960512506094,0.052598895472879,-0.111653440251904,0.0945342300017818,0.87073284351103
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20690.Liking for melon,36327,0.0186913171005215,0.0540469488803385,-0.0872407027049419,0.124623336905985,0.729477063662211
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20691.Liking for milk chocolate,36327,0.03445992806447,0.0520081079705653,-0.0674759635578381,0.136395819686778,0.507616141286306
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20692.Liking for mushrooms,36327,-0.0755477192218155,0.0543083773037856,-0.181992138737235,0.0308967002936043,0.164242257008042
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20694.Liking for orange juice,36327,0.118865839981613,0.0525546190243115,0.0158587866939626,0.221872893269264,0.0237423589529859
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20695.Liking for oranges,36327,0.0199477745833226,0.053690701670896,-0.0852860006916336,0.125181549858279,0.710252918851973
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20696.Liking for pasta,36327,0.0416239793493693,0.0526779224305879,-0.061624748614583,0.144872707313322,0.429460720307471
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20697.Liking for pears,36327,-0.0622965679211451,0.0540734688840354,-0.168280566933854,0.0436874310915643,0.249329854793409
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20698.Liking for pizza,36327,0.0264565383973856,0.0526779834743743,-0.0767923092123879,0.129705386007159,0.615520266924243
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20699.Liking for plain yogurt,36327,0.0378388053417845,0.0524560203515839,-0.06497499454732,0.140652605230889,0.470721918114884
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20700.Liking for plums,36327,0.0488053519881061,0.0541619811591165,-0.0573521310837622,0.154962835059974,0.367565704926334
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20701.Liking for pollock,36327,-0.0884683662820803,0.0523958045050523,-0.191164143111983,0.0142274105478223,0.0913661923706076
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20702.Liking for pork chop,36327,-0.07664747957413,0.0526081722335085,-0.179759497151807,0.0264645380035466,0.145174240335509
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20703.Liking for porridge,36327,-0.0822124937309918,0.0540600907946961,-0.188170271688596,0.0237452842266126,0.12836413067876
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20704.Liking for potato crisps,36327,0.0644819603702605,0.0525266493061304,-0.038470272269755,0.167434193010276,0.219635966386747
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20705.Liking for potatoes,36327,0.0397973119984961,0.0533601481107103,-0.064788578298496,0.144383202295488,0.455797971900838
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20706.Liking for prawns,36327,0.0160543063841373,0.0535430039918177,-0.0888899814398253,0.1209985942081,0.764308348477544
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20707.Liking for raw carrots,36327,0.017611231049258,0.0527201534750835,-0.0857202697619056,0.120942731860422,0.738350748885087
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20708.Liking for red meat,36327,0.0018230162536139,0.0521446585615576,-0.100380514527039,0.104026547034267,0.972112019973805
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20709.Liking for red wine,36327,0.131192795761713,0.0526491109760293,0.0280005382486958,0.234385053274731,0.0127311378282971
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36327,0.0296265202156327,0.0539526840908319,-0.0761207406023978,0.135373781033663,0.582940027231934
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20711.Liking for roast chicken,36327,-0.0400095086408755,0.0552954276274367,-0.148388546790651,0.0683695295089004,0.469360228800877
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20712.Liking for salad dressing,36327,-0.0152098606507552,0.0524522318665074,-0.11801623510911,0.0875965138075993,0.771843442365246
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20713.Liking for salad leaves,36327,-0.0155026687712948,0.0533366991951363,-0.120042599193762,0.0890372616511724,0.77132235447171
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20714.Liking for salami,36327,0.0447300959142052,0.0522219963478697,-0.0576250169276194,0.14708520875603,0.391729373601326
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20715.Liking for salmon,36327,-0.0810024207424209,0.0554503471217723,-0.189685101101095,0.0276802596162528,0.144111695643197
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20716.Liking for salty foods,36327,0.0847689590375077,0.052351969050089,-0.0178409003006667,0.187378818375682,0.105445828936612
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20717.Liking for salty pretzels,36327,0.0809592850758977,0.0524459123598757,-0.0218347031494588,0.183753273301254,0.122712235845451
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20718.Liking for sardines,36327,-0.0303727094509359,0.0523124040966084,-0.132905021480288,0.0721596025784166,0.561526792434386
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20719.Liking for sausages (meat),36327,0.0191327066221543,0.0523071084125408,-0.0833892258664256,0.121654639110734,0.714542780194977
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20720.Liking for savoury biscuits,36327,0.068960822831467,0.0526533496935759,-0.0342397425679419,0.172161388230876,0.190334880536833
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36327,-0.0381332330305447,0.0526057345485253,-0.141240472745654,0.0649740066845648,0.46854493180373
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20722.Liking for skimmed milk,36327,-0.0290055070974448,0.0527916600954317,-0.132477160884491,0.0744661466896012,0.582725204562136
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20723.Liking for smoked fish,36327,-0.00387794950579153,0.0523242007208257,-0.10643338291861,0.0986774839070268,0.940921852230833
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20724.Liking for soft cheese,36327,0.0163860127988826,0.0526229743521621,-0.0867550169313552,0.11952704252912,0.755516952546948
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20725.Liking for soy sauce,36327,-0.117956875863079,0.052727993774967,-0.221303743662014,-0.0146100080641435,0.0253117522801182
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20726.Liking for soya milk,36327,-0.0365388002332137,0.0528657065993494,-0.140155585167938,0.0670779847015111,0.489485872824264
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20727.Liking for spicy foods,36327,-0.00064688786006869,0.0526776452506071,-0.103895072551259,0.102601296831121,0.990202471130872
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20728.Liking for spinach,36327,0.0979781239629336,0.0524047936300374,-0.00473527155193977,0.200691519477807,0.0615747470868486
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20729.Liking for spirits,36327,0.0515393782588587,0.0519685390792447,-0.050318958336461,0.153397714854178,0.321357123429699
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20730.Liking for strawberries,36327,-0.0158544202230658,0.0576864806159958,-0.128919922230418,0.0972110817842861,0.783448894786738
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36327,-0.0719089507092024,0.0538917546717661,-0.177536789865864,0.0337188884474593,0.182141017816867
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20732.Liking for sweet foods,36327,0.0292377550314684,0.0523591977142276,-0.0733862724884177,0.131861782551355,0.576583880086456
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20733.Liking for taking the stairs,36327,0.0672316892325108,0.0533041956959694,-0.0372445343315892,0.171707912796611,0.207248113205141
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20734.Liking for tea with sugar,36327,-0.0392034461633299,0.0641055038236194,-0.164850233657624,0.0864433413309641,0.540857877661998
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20735.Liking for tea without sugar,36327,-0.0311611544469857,0.055037081050383,-0.139033833305736,0.0767115244117651,0.571286048729877
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20736.Liking for tomato ketchup,36327,-0.0500534786133315,0.0520997576286217,-0.15216900356543,0.052062046338767,0.336723652409809
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20737.Liking for tinned tuna,36327,-0.0304110163868154,0.052477069503131,-0.133266072612952,0.0724440398393214,0.562263042119673
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20738.Liking for turnip (white),36327,-0.0610548605599777,0.0523845005201736,-0.163728481579518,0.0416187604595626,0.243850081015348
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20739.Liking for vegetables,36327,-0.0267231919282418,0.0579860984624309,-0.140375944914606,0.0869295610581228,0.644916601446069
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20740.Liking for vinegar,36327,-0.128590716436018,0.0526759104020148,-0.231835500823967,-0.0253459320480685,0.014664042918486
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20741.Liking for watching television,36327,0.0129104317709569,0.0528303493604422,-0.0906370529755098,0.116457916517424,0.806947217669293
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20742.Liking for whisky,36327,0.0362512370349686,0.0534514452034342,-0.0685135955637624,0.1410160696337,0.497661382718771
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20743.Liking for white bread,36327,0.014870089925539,0.0518174483274001,-0.0866921087961652,0.116432288647243,0.774143093472897
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20744.Liking for white rice,36327,0.0693859062013999,0.052541819946217,-0.0335960608931855,0.172367873295985,0.186682408978319
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20745.Liking for white wine,36327,0.0987913594962758,0.0526559353680068,-0.00441427382501754,0.201996992817569,0.060673123250526
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36327,0.0247884307016674,0.053079748016576,-0.0792478754108216,0.128824736814156,0.640511620957288
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20747.Liking for whole milk,36327,0.0938847559707646,0.0523463177689137,-0.00871402685630633,0.196483538797835,0.0729304181644149
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20748.Liking for wholemeal bread,36327,0.11243567260174,0.0551853597136855,0.00427236756291677,0.220598977640564,0.0416450004982015
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20749.Liking for working up a sweat,36327,0.163573838830794,0.0531694449853702,0.0593617266594689,0.26778595100212,0.00210266818432278
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X21001.Body mass index (BMI),52472,-0.0907474243976451,0.012674567422048,-0.115589576544859,-0.065905272250431,8.31921182627353e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X21002.Weight,52491,0.0481185430743039,0.00682370966626129,0.0347440721284318,0.061493014020176,1.81722864144927e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X21021.Pulse wave Arterial Stiffness index,37159,-0.00198173937276852,0.00466477925630998,-0.0111247067151361,0.00716122796959904,0.670971894157967
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,36131,-0.0751255039435942,0.0566151603105257,-0.186091218152225,0.0358402102650362,0.184568829934214
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,36148,0.126295193185632,0.0567756145697167,0.0150149886289873,0.237575397742277,0.0261493717539407
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,36150,0.0285842302787336,0.0562708530710982,-0.0817066417406189,0.138875102298086,0.611486445227085
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21040.Satisfaction with bowel habits,36102,-0.0803978265910749,0.0522579637337973,-0.182823435509318,0.0220277823271678,0.123977180811626
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,36085,-0.150360337189247,0.0569480167536498,-0.2619784500264,-0.0387422243520934,0.00830175404269545
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21042.Greatest number of times bowels opened per day,36104,0.0729357102024559,0.0559492959935854,-0.0367249099449715,0.182596330349883,0.192412168036064
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21043.Least number of times bowels opened per week,36037,0.114634056919881,0.0564964378260137,0.00390103878089423,0.225367075058868,0.0424919105893019
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21044.Average number of times bowels opened per day,36067,0.00564979890842366,0.0631739436177393,-0.118171130582345,0.129470728399193,0.928740864968017
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,36154,0.0736410275598794,0.056549969661027,-0.0371969129757335,0.184478968095492,0.192881108621018
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,36149,0.0594991587047761,0.0571595974088868,-0.0525336522166419,0.171531969626194,0.297944071157848
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32844,-0.0876938602306089,0.0996279547826397,-0.282964651604583,0.107576931143365,0.378801684419382
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,36152,0.0581998934488973,0.0656580994120039,-0.0704899813986303,0.186889768296425,0.375428111987568
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,36151,0.117027017697041,0.0857188992159668,-0.0509820247662544,0.285036060160336,0.17222123879335
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,36149,0.058058674873668,0.0654170814931942,-0.0701588048529927,0.186276154600329,0.374832110090506
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,36149,-0.236107506721635,0.165290805131181,-0.56007748477875,0.0878624713354801,0.153211018308644
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,36155,0.0308163877323732,0.0670191825113538,-0.10054120998988,0.162173985454627,0.645663781613129
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,36151,0.13210764756091,0.0621564673228161,0.0102809716081907,0.25393432351363,0.0335879997541988
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,35991,-0.0751302992759451,0.0596359229175333,-0.19201670819431,0.0417561096424202,0.207778956687538
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,36145,0.00753628676494105,0.0571052023325697,-0.104389909806895,0.119462483336778,0.895010272782278
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,36151,0.212383648856737,0.0899433029755699,0.0360947750246198,0.388672522688854,0.0182381173593519
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,36156,0.0938455523209893,0.0575129193884078,-0.0188797696802899,0.206570874322269,0.102781625020443
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,36155,0.0110450960555698,0.0568041098360779,-0.100290959223143,0.122381151334283,0.845835600580546
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X21100.Water hardness (USGS classification),52442,0.00116350499403776,0.0299785478629229,-0.0575944488172912,0.0599214588053667,0.969041206591801
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2139.Age first had sexual intercourse,48594,0.00555492236994361,0.00312204148250315,-0.000564278935762575,0.0116741236756498,0.0752128586296404
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2149.Lifetime number of sexual partners,47394,0.0666820343977254,0.0342014613573379,-0.000352829862656848,0.133716898658108,0.051229157472263
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22032.IPAQ activity group,47386,0.128894841641056,0.0341316286169544,0.0619968495518255,0.195792833730287,0.000159614677134361
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22033.Summed days activity,47903,0.0100049098963819,0.00307056038828313,0.00398661153534699,0.0160232082574169,0.00112268470355076
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22034.Summed minutes activity,47386,0.0145273241968381,0.00304624299788511,0.00855668792098327,0.0204979604726929,1.86640299876031e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22037.MET minutes per week for walking,46390,0.0102693973905289,0.00326650385589274,0.00386704983297914,0.0166717449480787,0.0016702459086985
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22038.MET minutes per week for moderate activity,47386,0.0103713224601999,0.00296940634462226,0.00455128602474031,0.0161913588956596,0.000479252079184158
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22039.MET minutes per week for vigorous activity,47386,0.126085559207064,0.034083314361219,0.0592822630590746,0.192888855355053,0.000216802548274671
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22040.Summed MET minutes per week for all activity,46390,0.0142500509926346,0.00316792652115245,0.00804091501117585,0.0204591869740934,6.89712622444329e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X2217.Age started wearing glasses or contact lenses,50574,0.00449508233367018,0.00257466712696138,-0.000551265235174128,0.00954142990251448,0.0808446508916043
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X22501.Year ended full time education,34199,-0.00795689853351474,0.0128966332439546,-0.0332342996916658,0.0173205026246363,0.53727937013618
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X22506.Tobacco smoking,34167,0.0170033444966645,0.12901130139459,-0.235858806236733,0.269865495230062,0.895149935785749
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,51249,0.0184618355404748,0.11205418902232,-0.201164374943273,0.238088046024222,0.86913589276919
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23098.Weight,51994,0.0464235364030783,0.00689720897332503,0.0329050068153612,0.0599420659907953,1.72771678503904e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23099.Body fat percentage,51986,-0.0212843558935114,0.00655522122758879,-0.0341325894995854,-0.00843612228743738,0.00116824928455999
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23100.Whole body fat mass,51970,0.00404197445128038,0.00647136334201076,-0.00864189769906071,0.0167258466016215,0.532243841945179
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23101.Whole body fat-free mass,51993,0.043937878672063,0.00561286005467709,0.0329366729648959,0.0549390843792301,5.16878721929365e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23102.Whole body water mass,51994,0.0430966172985666,0.00563099610682028,0.0320598649291989,0.0541333696679344,2.03384950745321e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23104.Body mass index (BMI),51994,-0.0962868123885223,0.0126961917920887,-0.121171348301016,-0.0714022764760284,3.48085016475587e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23105.Basal metabolic rate,51994,0.0466206367815332,0.00599620346609082,0.0348680779879952,0.0583731955750712,7.86136029747613e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23106.Impedance of whole body,51991,-0.0100565213954621,0.00458327811887446,-0.019039746508456,-0.00107329628246812,0.0282327738990986
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23107.Impedance of leg (right),51994,-0.0240888732941221,0.00370314257412159,-0.0313470327394004,-0.0168307138488438,7.93145048512961e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23108.Impedance of leg (left),51994,-0.0213546631648301,0.00367789273029299,-0.0285633329162043,-0.0141459934134558,6.47457868638725e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23109.Impedance of arm (right),51991,0.00592058533213334,0.00452705800088755,-0.00295244834960626,0.0147936190138729,0.190946931877756
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23110.Impedance of arm (left),51994,0.00692339605941746,0.00454360846513902,-0.00198207653225502,0.0158288686510899,0.12758104708265
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23111.Leg fat percentage (right),51994,-0.0612694987531279,0.00770463186490916,-0.0763705772083498,-0.0461684202979059,1.91543848880931e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23112.Leg fat mass (right),51994,-0.0147519303772615,0.00845751500154763,-0.0313286597802948,0.00182479902577188,0.0811308398036655
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23113.Leg fat-free mass (right),51993,0.0556553420665818,0.00570637320187539,0.0444708505909061,0.0668398335422576,1.97762838202749e-22
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23114.Leg predicted mass (right),51993,0.0562630973691347,0.0057413935505542,0.0450099660100485,0.067516228728221,1.25343596486286e-22
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23115.Leg fat percentage (left),51991,-0.0604296599888099,0.00809287178785154,-0.0762916886929989,-0.0445676312846208,8.49723792307561e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23116.Leg fat mass (left),51991,-0.00950741959084343,0.00884919509506777,-0.0268518419771763,0.0078370027954894,0.282662692277749
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23117.Leg fat-free mass (left),51990,0.0566831626023696,0.00600401205990651,0.0449152989649529,0.0684510262397864,4.04000885805167e-21
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23118.Leg predicted mass (left),51990,0.0574978828555016,0.00604131978359454,0.0456568960796563,0.0693388696313469,1.94552230159277e-21
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23119.Arm fat percentage (right),51990,-0.0217523812504647,0.00739731106143891,-0.036251110930885,-0.00725365157004444,0.00327927993050301
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23120.Arm fat mass (right),51988,0.00125627380814954,0.00739274691018358,-0.0132335101358103,0.0157460577521094,0.865064107943484
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23121.Arm fat-free mass (right),51989,0.0319704802796665,0.0057383199815259,0.0207233731158757,0.0432175874434572,2.55552920867087e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23122.Arm predicted mass (right),51989,0.0315176552877878,0.00574989882355733,0.0202478535936154,0.0427874569819602,4.26378241616625e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23123.Arm fat percentage (left),51988,-0.0189604008042189,0.00757046232932304,-0.0337985069696921,-0.00412229463874576,0.0122685712539588
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23124.Arm fat mass (left),51988,0.00417221387915734,0.00739956862621706,-0.0103309406282281,0.0186753683865428,0.572864792926299
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23125.Arm fat-free mass (left),51988,0.0314830420485515,0.00585621567295195,0.0200048593295657,0.0429612247675373,7.69052313163445e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23126.Arm predicted mass (left),51986,0.029177223712114,0.00586062600477251,0.0176903967427599,0.0406640506814681,6.45408849146434e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23127.Trunk fat percentage,51985,-0.00562418586734069,0.00469329052512743,-0.0148230352965905,0.00357466356190907,0.230794811337919
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23128.Trunk fat mass,51985,0.00959950497548506,0.0052504307670362,-0.000691339327905896,0.019890349278876,0.067513535309368
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23129.Trunk fat-free mass,51984,0.0320564707886522,0.00506846301446741,0.022122283280296,0.0419906582970083,2.58449158980394e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23130.Trunk predicted mass,51981,0.0320535115773646,0.00508320846846165,0.0220904229791797,0.0420166001755494,2.9204002314453e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23400.Total Cholesterol,42754,0.0200160845135875,0.00360926803400101,0.0129419191669455,0.0270902498602295,2.98177721410861e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,42754,0.0232790935308388,0.00350055369338918,0.016418008291796,0.0301401787698816,3.04077708756549e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",42754,0.0272946536140054,0.00349577927460136,0.0204429262357867,0.0341463809922241,6.24045852818046e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23403.VLDL Cholesterol,42754,0.0310852217435906,0.00355251032008945,0.0241223015162153,0.0380481419709659,2.37825163704613e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23404.Clinical LDL Cholesterol,42754,0.0172837361020194,0.00349777405633418,0.0104280989516044,0.0241393732524344,7.85082573768374e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23405.LDL Cholesterol,42754,0.0191104789325169,0.00351478544871684,0.0122214994530319,0.0259994584120019,5.50712635547125e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23406.HDL Cholesterol,42754,-0.00688971769746515,0.00403466687942061,-0.0147976647811295,0.00101822938619925,0.0877279319297866
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23407.Total Triglycerides,42754,0.0264714438943326,0.00384162454246538,0.0189418597911005,0.0340010279975647,5.79735678351393e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23408.Triglycerides in VLDL,42754,0.0250815576878391,0.00382705498166659,0.0175805299237725,0.0325825854519056,5.8138335462748e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23409.Triglycerides in LDL,42754,0.0264873467353242,0.00381163901902129,0.0190165342580424,0.0339581592126059,3.84492431734436e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23410.Triglycerides in HDL,42754,0.0252114238819534,0.00376252479394139,0.0178368752858283,0.0325859724780786,2.15662280670345e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,42754,0.0205123049676732,0.00374450348593083,0.0131730781352488,0.0278515318000977,4.37884127439275e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23412.Phospholipids in VLDL,42754,0.0312598787350425,0.00366683606906388,0.0240728800396773,0.0384468774304077,1.68788030745691e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23413.Phospholipids in LDL,42754,0.0179871759929494,0.00349429576508473,0.0111383562933833,0.0248359956925155,2.67555486640803e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23414.Phospholipids in HDL,42754,-0.00194825000234816,0.00401073790612473,-0.00980929629835263,0.00591279629365631,0.627146254796766
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23415.Total Esterified Cholesterol,42754,0.0182169378449068,0.00362750313593818,0.011107031698468,0.0253268439913457,5.18144288343783e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,42754,0.0306340861161518,0.00351088212462121,0.0237527571518943,0.0375154150804094,2.95685856927728e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23417.Cholesteryl Esters in LDL,42754,0.0203667606684333,0.00351936952818386,0.0134687963931929,0.0272647249436737,7.32174276097401e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23418.Cholesteryl Esters in HDL,42754,-0.00979827477877374,0.00401279979777525,-0.0176633623824132,-0.00193318717513424,0.014628743958159
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23419.Total Free Cholesterol,42754,0.0241652165811399,0.0035674583461223,0.0171729982227402,0.0311574349395397,1.30623240679326e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23420.Free Cholesterol in VLDL,42754,0.0308236796814447,0.00362466361816386,0.0237193389898435,0.0379280203730458,2.02393005609686e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23421.Free Cholesterol in LDL,42754,0.0152646195346596,0.00351999072638246,0.00836543771095001,0.0221638013583693,1.45780833953198e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23422.Free Cholesterol in HDL,42754,0.00390157659131052,0.00407701042510504,-0.00408936384189535,0.0118925170245164,0.338599467402005
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,42754,0.025392968654727,0.00360373535661663,0.0183296473557584,0.0324562899536956,1.92620777378661e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23424.Total Lipids in VLDL,42754,0.0301164974652461,0.00371675659165645,0.0228316545455995,0.0374013403848927,5.82293809629601e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23425.Total Lipids in LDL,42754,0.0198766155017004,0.00351251341973345,0.0129920891990228,0.0267611418043779,1.55519504492936e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23426.Total Lipids in HDL,42754,-0.00168844393462013,0.00403206372741114,-0.00959128884034595,0.0062144009711057,0.675402355466929
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,42754,-6.18999147525858e-05,0.00380668073093521,-0.00752299414738559,0.00739919431788042,0.987026519253845
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23428.Concentration of VLDL Particles,42754,0.0318999812267598,0.00361720565671674,0.024810258139595,0.0389897043139246,1.29473246366282e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23429.Concentration of LDL Particles,42754,0.0247852261971938,0.00348166873657656,0.0179611554735038,0.0316092969208839,1.14365780433112e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23430.Concentration of HDL Particles,42754,-0.0049106454749169,0.00381373869695258,-0.012385573320944,0.00256428237111016,0.197900316836791
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23431.Average Diameter for VLDL Particles,42754,0.0167225482149825,0.0038948476925607,0.00908864673756357,0.0243564496924015,1.77096641294856e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23432.Average Diameter for LDL Particles,42754,-0.00131182843451612,0.00371383724291098,-0.00859094943062164,0.00596729256158939,0.723923587738173
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23433.Average Diameter for HDL Particles,42754,0.0070745837161493,0.00416993220426207,-0.00109848340420436,0.015247650836503,0.0898008538242432
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23434.Phosphoglycerides,42743,0.0164129035288637,0.00381748740164407,0.00893062822164133,0.0238951788360861,1.72458990773649e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,42743,0.0237917479865326,0.00398982070797551,0.0159716993989006,0.0316117965741646,2.53638306558315e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23436.Total Cholines,42743,0.0164313830512932,0.00382134721465147,0.00894154251057631,0.0239212235920101,1.72076171767004e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23437.Phosphatidylcholines,42743,0.018959525526962,0.00385003158221878,0.0114134636258131,0.0265055874281108,8.55681758451333e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23438.Sphingomyelins,42743,0.0118132535942594,0.00374920277346571,0.00446481615826664,0.0191616910302522,0.00163138778103225
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23439.Apolipoprotein B,42754,0.0259852341577229,0.00347998594498066,0.0191644617055608,0.0328060066098849,8.70129528180335e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23440.Apolipoprotein A1,42754,-0.00243877248288488,0.00393649634368476,-0.010154305316507,0.00527676035073725,0.535578526655716
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,42754,0.0244558863654571,0.00356545070347897,0.0174676029866384,0.0314441697442759,7.22845926717015e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23442.Total Fatty Acids,42743,0.0242392031865796,0.00371287082203088,0.0169619763753991,0.0315164299977601,6.88319090987831e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23443.Degree of Unsaturation,42743,-0.0102537952414982,0.00377480773944632,-0.017652418410813,-0.0028551720721834,0.00660847675736611
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23444.Omega-3 Fatty Acids,42743,0.02044618940621,0.00374129387301982,0.0131132534150911,0.0277791253973288,4.71075791811656e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23445.Omega-6 Fatty Acids,42743,0.0178022284326371,0.00366059001056164,0.0106274720119363,0.0249769848533379,1.16792537393363e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,42743,0.020511849531109,0.00370902320231831,0.0132421640545652,0.0277815350076529,3.25683388771163e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23447.Monounsaturated Fatty Acids,42743,0.0224736846400222,0.00380537470083334,0.0150151502263889,0.0299322190536555,3.59403984319045e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23448.Saturated Fatty Acids,42743,0.0246623376317498,0.00371305998679033,0.0173847400576407,0.0319399352058588,3.21148514721228e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23449.Linoleic Acid,42743,0.0206878240614873,0.00358458666038957,0.0136620342071238,0.0277136139158509,8.03707208356349e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23450.Docosahexaenoic Acid,42743,0.0100421021680227,0.00373759357107891,0.00271641876870799,0.0173677855673373,0.00722318668740924
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,42743,0.0101251953438319,0.00370242874417606,0.00286843500524684,0.017381955682417,0.00625099403742968
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,42743,-0.019009439152394,0.00398220499523291,-0.0268145609430505,-0.0112043173617374,1.82856235937423e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,42743,-0.0146324097458065,0.00393308549984289,-0.0223412573254985,-0.00692356216611441,0.000199759555450411
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,42743,0.0108645627667549,0.00398469703502262,0.00305455657811057,0.0186745689553992,0.00640783267741938
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,42743,0.0127610039244998,0.00361182032754954,0.00568183608250272,0.0198401717664969,0.000412048932288285
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,42743,0.000147925590499651,0.00382677682579737,-0.0073525569880632,0.0076484081690625,0.969165701635995
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,42743,-0.00383140718218124,0.00369448836278861,-0.0110726043732469,0.00340979000888445,0.299726266668999
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,42743,-0.0128798970266736,0.00399308132132733,-0.0207063364164752,-0.00505345763687205,0.00126027711259659
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,42743,-0.014478199224939,0.00366271023564631,-0.0216571112868057,-0.00729928716307219,7.76131623280829e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23460.Alanine,42748,0.00217440622363209,0.00361225735789334,-0.00490561819783886,0.00925443064510304,0.547216031930479
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23461.Glutamine,42709,0.00398257512528145,0.00362889163790597,-0.00313005248501424,0.0110952027355771,0.27245850009627
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23462.Glycine,42738,0.0237236083302973,0.00385165859894972,0.0161743574763558,0.0312728591842387,7.51236756301649e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23463.Histidine,42735,-0.0100675085693391,0.0035703725219939,-0.0170654387124472,-0.00306957842623109,0.00481329605478194
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),42744,0.00234931860913663,0.00377314504895814,-0.00504604568682133,0.00974468290509459,0.533530277621332
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23465.Isoleucine,42750,0.00133491268609396,0.00367543788409562,-0.00586894556673346,0.00853877093892138,0.716462441951422
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23466.Leucine,42750,0.00530196428862702,0.00372162782738372,-0.00199242625304507,0.0125963548302991,0.154285522084699
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23467.Valine,42744,0.000582737590390453,0.00380985181703306,-0.00688457197099434,0.00805004715177525,0.878435686885645
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23468.Phenylalanine,42747,-0.0022040675397598,0.00361277479113553,-0.00928510613038544,0.00487697105086584,0.541821629244512
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23469.Tyrosine,42738,-0.00449192734632084,0.0036658456883837,-0.0116769848955529,0.00269313020291121,0.220466397282474
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23470.Glucose,42728,-0.0219643147273417,0.00356493731616591,-0.0289515918670269,-0.0149770375876565,7.42393273618517e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23471.Lactate,42730,0.0126089189261798,0.00357040046923897,0.00561093400647141,0.0196069038458882,0.000414562362198373
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23472.Pyruvate,42712,0.0052591327901307,0.00361612661420348,-0.00182847537370813,0.0123467409539695,0.145871052269492
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23473.Citrate,42751,-0.00576861616742341,0.00361974797279673,-0.012863322194105,0.00132608985925818,0.111037463158541
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23474.3-Hydroxybutyrate,42525,-0.0175158097477313,0.0038030543178761,-0.0249697962107685,-0.0100618232846942,4.14841415170294e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23475.Acetate,42743,-0.00727519834348005,0.00355798725889838,-0.0142488533709209,-0.000301543316039226,0.0408986854496624
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23476.Acetoacetate,42752,-0.0204381136871472,0.00365189895286329,-0.0275958356347592,-0.0132803917395351,2.2287067777988e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23477.Acetone,42752,-0.00802801598688628,0.00362831526455585,-0.0151395139054158,-0.000916518068356808,0.0269417270097659
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23478.Creatinine,42434,0.0113998324407709,0.00406858280784986,0.0034254101373852,0.0193742547441567,0.00508736569902814
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23479.Albumin,42752,-0.00487964559282996,0.00362443663407545,-0.0119835413956178,0.00222425020995792,0.178222374283625
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23480.Glycoprotein Acetyls,42754,-0.011540769656519,0.0038262634884378,-0.0190402460938571,-0.00404129321918087,0.00256440016515907
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,42754,0.0224858890787221,0.00385816069958244,0.0149238941075405,0.0300478840499037,5.73233733901212e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,42754,0.0213100295515675,0.00381540677913943,0.0138318322644542,0.0287882268386807,2.37841673837382e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,42754,0.0203695991485359,0.00386606599411486,0.0127921098000707,0.027947088497001,1.39407361717756e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,42754,0.0242326425121593,0.00382925352412251,0.0167273056048792,0.0317379794194394,2.55683331451466e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,42754,0.0258417538567626,0.00378412781895413,0.0184248633316125,0.0332586443819127,8.91592037015679e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,42754,0.0217853587561572,0.00386548831943125,0.014209001650072,0.0293617158622425,1.77654995212222e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,42754,0.0200103875963607,0.00377931840080643,0.0126029235307801,0.0274178516619413,1.21067308658913e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,42754,0.0258316231867781,0.00384138330363021,0.0183025119116628,0.0333607344618933,1.83173394145697e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,42754,0.0257589355613068,0.0038219304545794,0.0182679518703312,0.0332499192522824,1.6504687449212e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,42754,0.0274302196204915,0.00380873556953936,0.0199650979041943,0.0348953413367886,6.24985363804534e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,42754,0.0290752929634529,0.00372157150705936,0.0217810128096165,0.0363695731172892,6.01063942843463e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,42754,0.0287913153366382,0.00366223263635562,0.0216133393693812,0.0359692913038952,4.07490329866061e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,42754,0.0281626740068367,0.00377995833755125,0.0207539556652363,0.0355713923484372,9.85884645362705e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,42754,0.0223450396376258,0.00384685126401581,0.0148052111601548,0.0298848681150968,6.43884576013328e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23495.Concentration of Large VLDL Particles,42754,0.0267168838249541,0.00379467727628473,0.019279316363436,0.0341544512864721,2.0059526238402e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23496.Total Lipids in Large VLDL,42754,0.0260440159040431,0.0037737030099702,0.0186475580045016,0.0334404738035847,5.37617475637445e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23497.Phospholipids in Large VLDL,42754,0.0269037320155285,0.00379162841180146,0.0194721403283977,0.0343353237026594,1.35223553700175e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23498.Cholesterol in Large VLDL,42754,0.0283258542643006,0.0037156571288621,0.0210431662917309,0.0356085422368703,2.63513486404622e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,42754,0.029252665148154,0.00364999506377322,0.0220986748231584,0.0364066554731495,1.19636042434482e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,42754,0.0264951579300859,0.00378485900021343,0.0190768342896676,0.0339134815705043,2.67421792173438e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23501.Triglycerides in Large VLDL,42754,0.023327531257744,0.00377090661608331,0.0159365542902207,0.0307185082252673,6.34091361912524e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,42754,0.028634532311595,0.00355572399082365,0.0216653132895806,0.0356037513336094,8.74304131343092e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23503.Total Lipids in Medium VLDL,42754,0.0286589131191741,0.00359559574234968,0.0216115454641687,0.0357062807741795,1.70514270740915e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23504.Phospholipids in Medium VLDL,42754,0.0293197110916172,0.00354039484000909,0.0223805372051993,0.036258884978035,1.3296786893575e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23505.Cholesterol in Medium VLDL,42754,0.0243630494205585,0.00347641923295749,0.0175492677239618,0.0311768311171552,2.53010609685948e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,42754,0.0206011806118711,0.00348810794797492,0.0137644890338403,0.0274378721899019,3.58648545388268e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,42754,0.0277963171636483,0.00351530282064311,0.0209063236351878,0.0346863106921088,2.83425913342687e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23508.Triglycerides in Medium VLDL,42754,0.0249327759417843,0.00373772005209641,0.0176068446396753,0.0322587072438932,2.64667823199004e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23509.Concentration of Small VLDL Particles,42754,0.0289648778681096,0.00367437492738828,0.0217631030104286,0.0361666527257906,3.44066556654242e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23510.Total Lipids in Small VLDL,42754,0.0287670002948638,0.00366376812696814,0.0215860147660062,0.0359479858237213,4.40941710868317e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23511.Phospholipids in Small VLDL,42754,0.0277226956054703,0.00357507838820688,0.0207155419645849,0.0347298492463558,9.50482408171064e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23512.Cholesterol in Small VLDL,42754,0.0277743596245215,0.00354013276743523,0.0208356994003485,0.0347130198486946,4.63115767253162e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,42754,0.0282484843410787,0.00355883196451373,0.0212731736906318,0.0352237949915256,2.22293865986365e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,42754,0.0261230023101663,0.0035126640841493,0.0192381807052337,0.0330078239150989,1.09336514231565e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23515.Triglycerides in Small VLDL,42754,0.023317796820695,0.00380808432832252,0.0158539515371828,0.0307816421042071,9.42257542858697e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,42754,0.0329967132878422,0.00357587386665032,0.0259880005092076,0.0400054260664768,3.17171435159896e-20
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,42754,0.0331623530079293,0.00361080702514955,0.0260851712386362,0.0402395347772224,4.73938363072524e-20
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,42754,0.0326862265449264,0.00361418340832169,0.0256024270646159,0.0397700260252369,1.7148964846363e-19
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,42754,0.0293625356864563,0.00356150939221516,0.0223819772777146,0.036343094095198,1.81135402996976e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,42754,0.0282371944329191,0.00356537374573313,0.0212490618912822,0.0352253269745561,2.56234000360197e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,42754,0.0308754847346265,0.00358256049159416,0.023853666171102,0.0378973032981511,7.54251913387468e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,42754,0.0266003631369426,0.00380447657438421,0.0191435890511495,0.0340571372227356,2.83963287415358e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23523.Concentration of IDL Particles,42754,0.0231927165524924,0.00346397204357314,0.0164033313470891,0.0299821017578958,2.23530882603623e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23524.Total Lipids in IDL,42754,0.0218874285147678,0.00356623008020706,0.0148976175575619,0.0288772394719736,8.621296876047e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23525.Phospholipids in IDL,42754,0.0241409031833732,0.00357371355901479,0.0171364246077042,0.0311453817590422,1.48525467538732e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23526.Cholesterol in IDL,42754,0.0186873127108439,0.00356443879918654,0.0117010126644383,0.0256736127572495,1.60613282801012e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23527.Cholesteryl Esters in IDL,42754,0.0189412351051632,0.00356710995157117,0.0119496996000837,0.0259327706102427,1.11375936816093e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23528.Free Cholesterol in IDL,42754,0.017625745735673,0.00355502388483979,0.0106578989213871,0.024593592549959,7.20902694584309e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23529.Triglycerides in IDL,42754,0.0286997801526307,0.00380503738993465,0.0212419068683587,0.0361576534369026,4.90048047569223e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23530.Concentration of Large LDL Particles,42754,0.0241280465494181,0.00348177853950717,0.0173037606119841,0.0309523324868522,4.40451800125961e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23531.Total Lipids in Large LDL,42754,0.0195437699192986,0.00353266910822932,0.0126197384671691,0.0264678013714281,3.2192223798546e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23532.Phospholipids in Large LDL,42754,0.017095932078258,0.00350722454639352,0.0102217719673267,0.0239700921891893,1.10324832130133e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23533.Cholesterol in Large LDL,42754,0.0189260337046415,0.00353968565158059,0.0119882498275436,0.0258638175817395,9.09684958752798e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,42754,0.0196370110401407,0.00353986181850309,0.0126988818758746,0.0265751402044068,2.95387062695355e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23535.Free Cholesterol in Large LDL,42754,0.0164720617555894,0.00354503121144514,0.00952380058115696,0.0234203229300219,3.40756817851953e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23536.Triglycerides in Large LDL,42754,0.0257525886579599,0.00380303865467188,0.018298632894803,0.0332065444211168,1.32626576780025e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23537.Concentration of Medium LDL Particles,42754,0.0227166727239666,0.00350434750479752,0.0158481516145635,0.0295851938333698,9.33829689618727e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23538.Total Lipids in Medium LDL,42754,0.0193521893125131,0.0035243383872379,0.0124444860735269,0.0262598925514994,4.06824149020901e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23539.Phospholipids in Medium LDL,42754,0.0180531821792527,0.00351710668027963,0.0111596530859046,0.0249467112726008,2.89159773641786e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23540.Cholesterol in Medium LDL,42754,0.0185865467059589,0.00351665001939876,0.0116939126679374,0.0254791807439805,1.27444931248588e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,42754,0.0202138499500427,0.00353502977531889,0.0132851915904177,0.0271425083096678,1.0995745496996e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,42754,0.0133968371071097,0.00350640831474613,0.00652427681020726,0.0202693974040121,0.000133682226737649
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23543.Triglycerides in Medium LDL,42754,0.0258215796526554,0.00381852950491453,0.0183372618230229,0.0333058974822879,1.41497768135793e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23544.Concentration of Small LDL Particles,42754,0.027762652009149,0.00348309016866201,0.0209357952785715,0.0345895087397265,1.70328506469008e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23545.Total Lipids in Small LDL,42754,0.0219029633119652,0.0034883484038492,0.0150658004404208,0.0287401261835097,3.51391776423725e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23546.Phospholipids in Small LDL,42754,0.0198838101183974,0.00346222440675512,0.0130978502811574,0.0266697699556375,9.49675653973745e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23547.Cholesterol in Small LDL,42754,0.020531949940316,0.003487735902564,0.0136959875712905,0.0273679123093414,4.02811410441367e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,42754,0.0233094179220506,0.00350879245948151,0.0164321847014668,0.0301866511426344,3.18772562490481e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23549.Free Cholesterol in Small LDL,42754,0.0121412045124757,0.00347984127962952,0.00532071560440188,0.0189616934205496,0.000486349610264576
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23550.Triglycerides in Small LDL,42754,0.0283304387853534,0.00383997683603321,0.0208040841867283,0.0358567933839785,1.7032195069954e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,42754,0.0198528690569539,0.00399439271303651,0.0120238593394023,0.0276818787745054,6.77057039559416e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23552.Total Lipids in Very Large HDL,42754,0.013945046914637,0.00401702884417807,0.00607167038004796,0.021818423449226,0.000519204173143223
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23553.Phospholipids in Very Large HDL,42754,0.0128367080192197,0.00404395066531188,0.00491056471520844,0.020762851323231,0.00150534624903898
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23554.Cholesterol in Very Large HDL,42754,0.0110534360070431,0.00397376590543332,0.00326485483239379,0.0188420171816924,0.00541659920649482
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,42754,0.00955367728918433,0.00401367270291,0.00168687879148074,0.0174204757868879,0.0173130779171634
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,42754,0.0149978370119052,0.0038039940180069,0.00754200873661168,0.0224536652871987,8.09893778051658e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23557.Triglycerides in Very Large HDL,42754,0.0369285102359475,0.00373985538782197,0.0295983936758164,0.0442586267960786,6.42807126784721e-23
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23558.Concentration of Large HDL Particles,42754,0.00466535483637444,0.0041735044392058,-0.00351471386446893,0.0128454235372178,0.263650570029915
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23559.Total Lipids in Large HDL,42754,0.00187404240884365,0.00418101090846422,-0.00632073897174622,0.0100688237894335,0.653996465402295
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23560.Phospholipids in Large HDL,42754,-9.88029825703123e-05,0.00417842035436229,-0.0082885068771204,0.00809090091197977,0.981135317159983
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23561.Cholesterol in Large HDL,42754,0.000131394130957627,0.00413610147752433,-0.00797536476499007,0.00823815302690532,0.974657830669571
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,42754,-0.00151921795739029,0.00412809580573217,-0.00961028573662534,0.00657184982184476,0.712864763047433
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23563.Free Cholesterol in Large HDL,42754,0.00547537026026341,0.00414504803385588,-0.00264892388609411,0.0135996644066209,0.186542816143227
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23564.Triglycerides in Large HDL,42754,0.0305914904012501,0.00386198499826802,0.0230219998046448,0.0381609809978554,2.53496216354352e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23565.Concentration of Medium HDL Particles,42754,-0.00632709170273681,0.00390497407545013,-0.0139808408906191,0.00132665748514545,0.105198678096061
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23566.Total Lipids in Medium HDL,42754,-0.00705514956052057,0.0038740493845078,-0.0146482863541559,0.000537987233114718,0.0686090448461315
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23567.Phospholipids in Medium HDL,42754,-0.00580546885826745,0.00385525809271339,-0.0133617747199857,0.0017508370034508,0.132127081917396
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23568.Cholesterol in Medium HDL,42754,-0.0125515514644686,0.00389270351915358,-0.0201812503620097,-0.00492185256692761,0.00126545110231046
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,42754,-0.0144407921086207,0.0038722714185131,-0.0220304440889064,-0.00685114012833501,0.000192808251684476
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,42754,-0.00422579685757818,0.00396202312652083,-0.011991362185559,0.00353976847040264,0.286182550896371
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23571.Triglycerides in Medium HDL,42754,0.0217585362598084,0.00374626876509084,0.0144158494802304,0.0291012230393865,6.46196511852936e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23572.Concentration of Small HDL Particles,42754,-0.00652250839250484,0.0035880492243656,-0.0135550848722614,0.000510068087251732,0.0691102642807179
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23573.Total Lipids in Small HDL,42754,-0.00369987290946456,0.00361755132077646,-0.0107902734981864,0.00339052767925729,0.306441394701613
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23574.Phospholipids in Small HDL,42754,-0.00369159627908279,0.00363984046209518,-0.0108256835847893,0.00344249102662377,0.310496239099245
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23575.Cholesterol in Small HDL,42754,-0.00922565852661754,0.00358419331678216,-0.0162506774275106,-0.00220063962572452,0.0100639908426807
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,42754,-0.0134320473264388,0.00356394502598339,-0.0204173795773662,-0.00644671507551136,0.000164682919671152
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23577.Free Cholesterol in Small HDL,42754,0.00482585214529709,0.00367541956981459,-0.0023779702115395,0.0120296745021337,0.189202760582954
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23578.Triglycerides in Small HDL,42754,0.0196247536888684,0.00381337365752899,0.0121505413201116,0.0270989660576252,2.69390961901467e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42256,-0.00975680978101387,0.00366236862831904,-0.0169350522925192,-0.00257856726950855,0.00772960639262077
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42256,-0.000798395171215,0.00377524571904333,-0.00819787678053993,0.00660108643810993,0.832514753613471
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42256,0.0044963505486484,0.0037357839515658,-0.00282578599642056,0.0118184870937174,0.228770070137913
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42256,-0.0111926179375249,0.00379035233620123,-0.0186217085164793,-0.0037635273585705,0.00315341059600234
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42256,0.0030183500090746,0.00374852189042482,-0.00432875289615804,0.0103654529143072,0.420712748259653
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,42631,0.0237663509729128,0.00365044189398645,0.0166114848606993,0.0309212170851262,7.75414815621532e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,42631,0.0029461987390772,0.00382474872375489,-0.00455030875948238,0.0104427062376368,0.441136305585704
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,42631,-0.000206340504947511,0.00382968920526228,-0.00771253134726157,0.00729985033736655,0.957032227393509
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,42631,0.0140095816659196,0.00377081011793716,0.00661879383476274,0.0214003694970764,0.000203808569741463
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,42631,-0.0109788128983576,0.00375088875474269,-0.0183305548576532,-0.00362707093906191,0.0034283377977462
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,42753,0.0218703732570399,0.00372935248281556,0.0145608423907214,0.0291799041233584,4.61288417217401e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,42753,0.00813499167483507,0.00362660181231037,0.00102685212270675,0.0152431312269634,0.0249035851080013
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,42753,0.00806512073952391,0.00372998914989194,0.000754342005735713,0.0153758994733121,0.0306173411455629
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,42753,0.00528942009211504,0.00357932300111357,-0.00172605299006755,0.0123048931742976,0.139492282922998
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,42753,-0.0149129829735056,0.00356537062397022,-0.0219011093964872,-0.00792485655052394,2.89841154437978e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,42754,0.0166081776854766,0.00361914903424286,0.00951464557836061,0.0237017097925926,4.49427352088486e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,42754,0.0036243016870872,0.00375743904714131,-0.00374027884530976,0.0109888822194842,0.334778939012496
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,42754,0.00154801043625879,0.00379741567404812,-0.00589492428487554,0.00899094515739311,0.683538258390424
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,42754,0.00896449761762673,0.00366541303686399,0.00178028806537331,0.0161487071698801,0.0144697809164895
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,42754,-0.00678530151090322,0.00372320055618597,-0.0140827746010277,0.000512171579221276,0.0684105933735745
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,42754,0.00270096418089972,0.00374576966087906,-0.00464074435442324,0.0100426727162227,0.470878541992772
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,42754,0.00888774038510062,0.00364942336294746,0.0017348705937236,0.0160406101764776,0.0148888688511271
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,42754,0.0111048703572924,0.0035798949240816,0.00408827630609248,0.0181214644084924,0.0019260605349253
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,42754,0.00456927198449491,0.00376030078122218,-0.00280091754670057,0.0119394615156904,0.224335875570723
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,42754,-0.00726525640276459,0.00368180883812749,-0.0144816017254945,-4.89110800347024e-05,0.0484834288468936
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,42754,0.000375678538217589,0.00366662202773113,-0.00681090063613543,0.00756225771257061,0.918393845605344
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,42754,0.00581952686028251,0.00379309234091141,-0.00161493412790386,0.0132539878484689,0.124993116267136
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,42754,0.00630717246324703,0.0038248168221893,-0.00118946850824399,0.0138038134347381,0.0991681464707412
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,42754,0.000122987263866986,0.00359316658821132,-0.00691961924902719,0.00716559377676116,0.972695763216926
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,42754,-0.00643353648173358,0.00377745970454485,-0.0138373575026415,0.000970284539174329,0.0885650966928983
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,42754,0.00669066000324961,0.00345528883235879,-8.17061081736159e-05,0.0134630261146728,0.0528451951614476
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,42754,-0.00417468880718911,0.00365676435330673,-0.0113419469396703,0.00299256932529209,0.253626084172909
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,42754,-0.00189774064245337,0.00365160711932654,-0.00905489059633339,0.00525940931142665,0.603281089317182
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,42754,-0.0102448152457681,0.00351335215591441,-0.0171309854713604,-0.00335864502017586,0.0035517005360645
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,42754,0.00122660815343626,0.00377334590164772,-0.00616914981379328,0.00862236612066579,0.745131784563875
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,42754,-0.0192975640748727,0.00349935196977574,-0.0261562939356332,-0.0124388342141123,3.55948116533244e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,42754,0.00781296743861985,0.00379382908460238,0.000377062432799176,0.0152488724444405,0.0394760988781911
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,42754,0.0108552689034835,0.00353920599094072,0.00391842516123968,0.0177921126457273,0.00216537496132318
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,42754,-0.00409752448233841,0.00378756812043213,-0.0115211579983854,0.00332610903370857,0.279345004614288
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,42754,0.00037474252278031,0.0037836166226615,-0.00704114605763624,0.00779063110319686,0.921105219029141
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,42754,-0.0167043003485994,0.0035900866218284,-0.0237408701273831,-0.00966773056981578,3.30401604069934e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,42754,0.00508407640382439,0.00349862288978267,-0.00177322446014964,0.0119413772677984,0.146201082332836
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,42754,0.0182280205553105,0.00361767645749944,0.0111373746986116,0.0253186664120094,4.74988203253837e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,42754,-0.0171314366128047,0.00386880904692365,-0.0247143023447751,-0.00954857088083438,9.58146035523742e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,42754,0.0021490278713243,0.00371755486967725,-0.0051373796732431,0.0094354354158917,0.563222659246349
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,42754,-0.0150274052844208,0.00355088842125164,-0.021987146590074,-0.0080676639787676,2.33132621282355e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,42754,0.00391672123412672,0.00357340416094218,-0.00308715092131995,0.0109205933895734,0.273065142125435
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,42754,0.0191910085077668,0.00355078777788172,0.0122314644631186,0.0261505525524149,6.60080006105415e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,42754,-0.0178777869290179,0.00379612171499796,-0.0253181854904139,-0.0104373883676219,2.50802245222967e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,42754,0.00937111447451532,0.00379412728382929,0.00193462499820992,0.0168076039508207,0.0135273048288578
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,42745,0.00617884536686698,0.00395200061136633,-0.00156707583141103,0.013924766565145,0.117964785328769
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,42745,-0.0207330032745701,0.00373101119071495,-0.0280457852083714,-0.0134202213407688,2.79725078005361e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,42745,-0.019229618743689,0.00362337700553221,-0.0263314376745321,-0.0121277998128458,1.13139579178657e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,42745,-0.00774547448834802,0.00413586432741094,-0.0158517685700735,0.000360819593377424,0.0611232746851721
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,42745,0.0159529394426521,0.0039452242928092,0.00822029982874604,0.0236855790565581,5.292624874827e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,42754,-0.0177583182328354,0.00383823223642546,-0.0252812534162293,-0.0102353830494415,3.74992038925366e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,42754,-0.0019933014213757,0.00396572556809263,-0.00976612353483725,0.00577952069208586,0.615231038987322
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,42754,-0.00688527585578635,0.00399280075655759,-0.0147111653386392,0.000940613627066529,0.0846543703801938
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,42754,0.0164200937038634,0.0037644229727487,0.00904182467727592,0.0237983627304508,1.2988075433812e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,42754,0.0231323313250258,0.00392048828052134,0.015448174295204,0.0308164883548476,3.71339222277567e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,42754,0.0108787543808699,0.00389711378010526,0.00324041137186361,0.0185170973898762,0.00525393540782271
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,42754,-0.0221471398700266,0.00386160404663536,-0.0297158838014319,-0.0145783959386213,9.9465021163879e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,42754,-0.0264670850601475,0.00383745750089026,-0.0339885017618924,-0.0189456683584026,5.54512865335997e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,42754,0.00561434091255313,0.00404672876369789,-0.00231724746429472,0.013545929289401,0.165349446403088
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,42754,0.0278088343064946,0.0038088862224027,0.0203434173105853,0.0352742513024039,3.01452281371832e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,42754,-0.000616774627981382,0.0037341156448906,-0.00793564129196695,0.00670209203600418,0.868810374408186
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,42754,-0.0160071155528942,0.00372913089512561,-0.0233162121073404,-0.008698018998448,1.77937707230203e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,42754,-0.0235133007094959,0.00376457370660106,-0.030891865174434,-0.0161347362445579,4.33839774248195e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,42754,0.0248123620842994,0.00371985165573106,0.0175214528390665,0.0321032713295322,2.65258631640976e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,42754,0.0254692694343503,0.00384676014472222,0.0179296195506947,0.0330089193180058,3.70291384817606e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,52298,-0.00158352707244602,0.00311833077849914,-0.00769545539830434,0.0045284012534123,0.611589752478132
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,52298,-0.0020625505987843,0.00303546526507551,-0.00801206251833231,0.0038869613207637,0.49683794110631
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50826,-0.00179284059888089,0.00289114884355508,-0.00745949233224885,0.00387381113448708,0.53518955812019
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50826,-0.00200874260247834,0.00317916039046477,-0.00823989696778928,0.0042224117628326,0.527493608130054
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50826,-0.00311911418226156,0.00309878034594225,-0.00919272366030837,0.00295449529578525,0.31415661792536
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50826,-0.0017329568952,0.00282426186468371,-0.00726851014998007,0.00380259635958007,0.539488519005488
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24009.Traffic intensity on the nearest road,52298,0.112551120063774,0.0664020596498912,-0.0175969168500132,0.24269915697756,0.0900899568353137
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24010.Inverse distance to the nearest road,52298,-0.0014644619581683,0.00272361558562592,-0.00680274850599509,0.00387382458965849,0.590795985692626
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24011.Traffic intensity on the nearest major road,52298,-0.00407778114135497,0.00268916551709198,-0.00934854555485525,0.0011929832721453,0.129438446618332
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24012.Inverse distance to the nearest major road,52298,0.00334739808252387,0.00273936387522237,-0.00202175511291198,0.00871655127795972,0.22173453024814
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24013.Total traffic load on major roads,52298,0.0219440356392471,0.0465334056364575,-0.0692614394082096,0.113149510686704,0.637233939403592
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24015.Sum of road length of major roads within 100m,52298,0.0484757989618975,0.0452111869003237,-0.0401381273627369,0.137089725286532,0.283637791162796
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,52298,-0.00266895470266844,0.00309913639795281,-0.00874326204265596,0.00340535263731907,0.389140668767358
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,52298,-0.00167729653818966,0.00309174618360296,-0.00773711905805146,0.00438252598167214,0.587473942006419
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,52298,-0.0016613626421964,0.00305748571202698,-0.00765403463776927,0.00433130935337648,0.586876574952774
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,52244,-0.00815615679378478,0.00304787461942471,-0.0141299910478572,-0.00218232253971235,0.0074556076477279
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24020.Average daytime sound level of noise pollution,52298,-0.00093598556352761,0.00273624040728825,-0.00629901676181258,0.00442704563475736,0.732301377982904
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24021.Average evening sound level of noise pollution,52298,-0.000949993305663877,0.00273671102686929,-0.00631394691832769,0.00441396030699994,0.728497145684145
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24022.Average night-time sound level of noise pollution,52298,-0.00094093607256075,0.00273626102945839,-0.0063040076902992,0.0044221355451777,0.730942238148634
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24023.Average 16-hour sound level of noise pollution,52298,-0.000931157841376593,0.00273637130954406,-0.00629444560808296,0.00443212992532977,0.733641777878367
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24024.Average 24-hour sound level of noise pollution,52298,-0.000925586181733598,0.00273631494227089,-0.00628876346858455,0.00443759110511735,0.73517025816024
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2405.Number of children fathered,40207,-0.0162790509362654,0.0525569322615753,-0.119290638168953,0.0867325362964221,0.7567635766412
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",49987,0.00310872665663333,0.00317431935760173,-0.00311293928426606,0.00933039259753272,0.327425159233464
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",49987,-0.00185082039649646,0.00285203094942826,-0.00744080105737585,0.00373916026438293,0.51637901543168
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24502.Water percentage, buffer 1000m",49987,0.00835935884564018,0.002891571478996,0.00269187874680803,0.0140268389444723,0.00384489397373375
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24503.Greenspace percentage, buffer 300m",49987,0.0031665017380465,0.00297242280930974,-0.0026594469682006,0.00899245044429359,0.286755649258062
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",49987,-0.00278188642977007,0.00286391463103517,-0.00839515910659901,0.00283138624705887,0.331381327523239
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24505.Water percentage, buffer 300m",49987,0.00724043170635302,0.0029155677664672,0.00152591888407731,0.0129549445286287,0.0130224259411177
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",52442,0.00160850642939141,0.00305520026618585,-0.00437968609233286,0.00759669895111567,0.59855872285089
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24507.Natural environment percentage, buffer 300m",52442,0.00053186603522355,0.00285618691621707,-0.00506626032056192,0.00612999239100902,0.852277459788299
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24508.Distance (Euclidean) to coast,52442,0.000313911951710775,0.00269625638644914,-0.00497075056572954,0.00559857446915109,0.907316639883068
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35608,0.00205293724756494,0.0610725798047655,-0.117649319169775,0.121755193664905,0.973185435517913
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2704.Years since last cervical smear test,38544,0.118886167003882,0.0519948864347812,0.0169761895917104,0.220796144416053,0.0222474357987576
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2714.Age when periods started (menarche),41013,0.116623957128992,0.0417418324874466,0.0348099654535969,0.198437948804388,0.0052154810591177
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2734.Number of live births,41368,0.00726703651800659,0.0403964926442602,-0.0719100890647434,0.0864441621007566,0.857239755685637
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2744.Birth weight of first child,39513,0.100412852806422,0.0435449609524848,0.0150647293395513,0.185760976273292,0.0211327178974445
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2754.Age at first live birth,38272,0.0122122138489635,0.00497893853751157,0.00245349431544081,0.0219709333824862,0.0141945920448554
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2764.Age at last live birth,38241,0.0108706874564662,0.00458321057408244,0.0018875947312646,0.0198537801816678,0.0177200834189668
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2794.Age started oral contraceptive pill,37164,0.00479166541891561,0.00714240019948783,-0.00920743897208054,0.0187907698099118,0.502318916495058
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2804.Age when last used oral contraceptive pill,36372,-0.0149863624008377,0.00537839028969198,-0.025528007368634,-0.00444471743304145,0.00534365044894495
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2867.Age started smoking in former smokers,36324,0.00553195543495771,0.0051709326535961,-0.00460307256609065,0.0156669834360061,0.284737569591446
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36148,-0.0420044996064337,0.0701996091023055,-0.179595733446952,0.095586734234085,0.549620559042894
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36144,-0.00793108031649905,0.0767234945419533,-0.158309129618728,0.142446968985729,0.917670518235212
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36161,-0.00412908009009833,0.0801411807894579,-0.161205794437436,0.152947634257239,0.958910590059421
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",36135,0.00971092654044001,0.0786007706241215,-0.144346583882838,0.163768436963718,0.901677162929079
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28739.Difficulty with standing for long periods,36168,-0.148947050431362,0.0595880491586009,-0.265739626782219,-0.0321544740805039,0.0124557188351624
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28740.Difficulty with taking care of household responsibilities,36190,-0.0829874580513052,0.0662853742179632,-0.212906791518513,0.0469318754159026,0.210621799235385
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28741.Difficulty learning a new task,36129,-0.0554377502139174,0.0760520198398809,-0.204499709100084,0.0936242086722492,0.466059847591076
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28742.Difficulty with joining in community activities,35861,-0.0626635962601079,0.0816730280420835,-0.222742731222591,0.0974155387023757,0.442960322797017
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28743.Difficulty with being emotionally affected by health problems,36146,-0.0642893241208781,0.0687230364698503,-0.198986475601785,0.0704078273600285,0.349571259381902
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36192,-0.110796452545347,0.104943524121991,-0.316485759824449,0.0948928547337541,0.291108776328236
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,35841,-0.0865542913869503,0.0586169904353442,-0.201443592640225,0.0283350098663243,0.139828235310614
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2897.Age stopped smoking,36326,-0.0070257682980661,0.00487598294228923,-0.016582694864953,0.00253115826882079,0.14965888823004
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35446,0.00989108648382976,0.0114030207734216,-0.0124588342320766,0.0322410071997362,0.385751068195231
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35446,-0.00593313068798791,0.0128201063108289,-0.0310605390572125,0.0191942776812367,0.643524649855369
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35446,0.0492967244528679,0.0417574281208336,-0.032547834663966,0.131141283569702,0.237826517678709
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35446,-0.0163448858494844,0.0491083291945152,-0.112597211070734,0.0799074393717654,0.739271301569826
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35446,-0.00647509243921691,0.0600118015086568,-0.124098223396184,0.111148038517751,0.914080871153781
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35446,-0.00110219552359676,0.0506373095569222,-0.100351322255164,0.0981469312079708,0.982634934827173
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35446,-0.00159206696519881,0.020774434135629,-0.0423099578710316,0.039125823940634,0.938915669863053
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35446,-0.0503468806303134,0.0352163148156629,-0.119370857669013,0.0186770964083859,0.152868473594972
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29002.Recent lack of interest or pleasure in doing things,35401,-0.129208532312932,0.0824841668343973,-0.29087749930835,0.0324604346824871,0.117290868563461
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29003.Recent feelings of depression,35389,-0.169316857183177,0.0801426558666199,-0.326396462681752,-0.0122372516846022,0.0346669340953436
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35402,-0.0516283637438371,0.0622930037628807,-0.173722651119083,0.070465923631409,0.40725016861828
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29005.Recent feelings of tiredness or low energy,35406,-0.140209485133688,0.0616746403948485,-0.261091780307591,-0.0193271899597847,0.0230376869661046
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29006.Recent poor appetite or overeating,35417,-0.164163108719273,0.0959217760093445,-0.352169789697588,0.0238435722590424,0.0870521797345159
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29007.Recent feelings of inadequacy,35382,-0.0618859010027637,0.0904608877844621,-0.239189241060309,0.115417439054782,0.493926426962926
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29008.Recent trouble concentrating on things,35416,-0.112131087599298,0.0871449038780739,-0.282935099200323,0.058672924001727,0.198239797739342
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35409,-0.0361786947842204,0.147057093856747,-0.324410598743445,0.252053209175004,0.805676411327579
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29010.Recent thoughts of suicide or self-harm,35388,-0.0198125791622183,0.167232576977069,-0.347588430037273,0.307963271712837,0.905696568833663
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29038#0.Substances taken for depression_None of options listed,36442,0.047885317596333,0.02253872366848,0.00370941920611229,0.0920612159865537,0.033655438457417
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),36442,0.0837486137233106,0.0587254247353257,-0.0313532187579277,0.198850446204549,0.153881143589638
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),36442,0.00634284739279593,0.0234393098157018,-0.0395981998459796,0.0522838946315715,0.78670081705723
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),36442,0.103601685222834,0.0713935911413902,-0.0363297534142909,0.243533123859959,0.146785758902424
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),36442,0.0357921515755545,0.0599181062919924,-0.0816473367567506,0.153231639907859,0.550291600524569
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),36442,-0.119929819241061,0.0625738984540378,-0.242574660210976,0.00271502172885262,0.0553266558772803
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),36442,-0.0582862389894866,0.0648906331913936,-0.185471880044618,0.0688994020656449,0.36909667642974
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),36442,0.0294945231078229,0.0633638332087361,-0.0946985899812999,0.153687636196946,0.64160257740308
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),36442,-0.00887208241402316,0.0412668900639889,-0.0897551869394415,0.0720110221113951,0.829779015356797
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,36442,0.0248690883751278,0.020812821131734,-0.0159240410430708,0.0656622177933265,0.232168046266019
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,36442,0.0209092318811283,0.0371293306751463,-0.0518642562421585,0.0936827200044151,0.57335292968116
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,36442,-0.0921014585776083,0.0575519912134166,-0.204903361355905,0.0207004442006883,0.109571749957162
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,36442,0.0489205381141634,0.0819236836441073,-0.111649881828287,0.209490958056614,0.550427435891595
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,36442,-0.0062526458616,0.0549150909347879,-0.113886224093784,0.101380932370584,0.909351731825709
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,36442,-0.00569491953455638,0.0774646374930598,-0.157525609020954,0.146135769951841,0.941397240604739
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,36442,-0.0320929127538328,0.0789381408957291,-0.186811668909462,0.122625843401796,0.684344839215653
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,36442,-0.0245167651991431,0.0449760905792471,-0.112669902734467,0.0636363723361811,0.585696955038241
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,36442,-0.0364794318322488,0.0418576328168445,-0.118520392153264,0.0455615284887664,0.383503489603969
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,36442,0.0300772318582309,0.0598609480873664,-0.0872502263930073,0.147404690109469,0.615365122907207
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29058.Recent feelings or nervousness or anxiety,35309,-0.0689897122516289,0.0736814443289481,-0.213405343136367,0.0754259186331094,0.349143329645499
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29059.Recent inability to stop or control worrying,35323,-0.123989102860711,0.0754054619108468,-0.27178380820597,0.0238056024845492,0.100165820683614
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29060.Recent worrying too much about different things,35320,-0.0649815390406086,0.07014235219493,-0.202460549342671,0.0724974712614541,0.354262327378915
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29061.Recent trouble relaxing,35316,-0.0386062289226052,0.0758365283456375,-0.187245824480055,0.110033366634844,0.610720334030931
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29062.Recent restlessness,35333,-0.0445456417029439,0.111277674419221,-0.262649883564616,0.173558600158729,0.688941635065589
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29063.Recent easy annoyance or irritability,35304,-0.0911742063984522,0.0773438629303172,-0.242768177741874,0.0604197649449695,0.238517250161343
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29064.Recent feelings of foreboding,35304,-0.146812670635154,0.0869203184301378,-0.317176494758225,0.0235511534879158,0.0912610938592198
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,36442,0.0376556091350183,0.0260674284943278,-0.0134365507138641,0.0887477689839008,0.148628573515896
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,36442,0.0324548863303327,0.0463494258460939,-0.0583899883280114,0.123299760988677,0.483811167128054
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',36442,0.0666215764968004,0.0570191105101543,-0.045135880103102,0.178379033096703,0.242680717788461
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,36442,0.119913439706438,0.0539227470488023,0.0142248554907859,0.225602023922091,0.0261925603153467
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#2.Symptoms of panic attack_Sweating,36442,-0.020971199225264,0.039955076341699,-0.099283148854994,0.0573407504044659,0.599689996235611
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,36442,0.034452598311107,0.0428085579293722,-0.0494521752304624,0.118357371852676,0.42095784760805
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,36442,0.0203921210288415,0.0427818367606459,-0.0634602790220244,0.104244521079707,0.633623102784454
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,36442,-0.00604090064813476,0.0427863915392845,-0.0899022280651324,0.0778204267688629,0.887725799917866
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,36442,-0.0214068032667367,0.0554848878421948,-0.130157183437438,0.087343576903965,0.699646326694126
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29076.Felt loved as a child,35301,-0.0519764458584611,0.0646693723873874,-0.17872841573774,0.0747755240208183,0.421586622990906
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29077.Physically abused by family as a child,35323,-0.0284235522872402,0.0955797236906201,-0.215759810720856,0.158912706146375,0.766186062719703
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29078.Felt hated by family member as a child,35308,-0.107194378607768,0.0946849843940952,-0.292776948020195,0.0783881908046587,0.257630121159295
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29079.Sexually molested as a child,35263,-0.222217568509458,0.1222886110046,-0.461903246078474,0.0174681090595585,0.0692424431742961
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29080.Someone to take to doctor when needed as a child,35281,0.0013978699821678,0.0886988056570961,-0.17245178910574,0.175247529070076,0.987426585224726
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35314,-0.0365570796142677,0.139155937272723,-0.309302716668804,0.236188557440269,0.792786147050245
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35267,-0.10352310891539,0.104351022207048,-0.308051112441205,0.101004894610425,0.321204825961317
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35320,-0.025800035541538,0.121038301473392,-0.263035106429387,0.211435035346311,0.831212410450358
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35308,0.271067635089262,0.167194324606516,-0.0566332411395101,0.598768511318034,0.105010688131147
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35307,-0.080993118116604,0.153916373206929,-0.382669209602185,0.220682973368977,0.598757864060112
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29086.Experienced a violent or sexual assault,35322,0.0724795624469584,0.148436567491228,-0.218456109835849,0.363415234729766,0.625364442032763
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29087.Experienced a life-threatening injury or illness,35315,-0.0804206797952788,0.0718128928167725,-0.221173949716153,0.0603325901255952,0.262815629836182
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29088.Experienced a marital separation or divorce,35321,-0.0134202250876881,0.0724097343942515,-0.155343304500421,0.128502854325045,0.852970614768803
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29089.Experienced the death of a spouse or partner,35329,-0.00699624253559928,0.0781635678269943,-0.160196835476508,0.14620435040531,0.928681342875705
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35320,-0.0510941292156326,0.092680855828971,-0.232748606640416,0.13056034820915,0.581454260838289
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29091.Frequency of drinking alcohol,35320,0.196080833127867,0.0583037205356725,0.0818055408779492,0.310356125377785,0.000775472441576195
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,34560,0.0997026558879147,0.0729709828543932,-0.0433204705066961,0.242725782282525,0.171891777346421
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,34585,0.164888336302428,0.0756043208984046,0.0167038673415554,0.313072805263301,0.0292311024720444
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29104.Ever used cannabis,35321,0.16488559681732,0.106846292614819,-0.0445331367077251,0.374304330342366,0.122833022803668
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29108.Ever thought that life not worth living,35286,-0.0760390401594466,0.0795396805452154,-0.231936814028069,0.0798587337091755,0.339115855683954
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29109.Ever contemplated self-harm,35312,0.00595179752770082,0.120033853842315,-0.229314556003236,0.241218151058637,0.960455257577628
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29111.Ever self-harmed,35320,0.12221134869482,0.214055751425171,-0.297337924098516,0.541760621488156,0.56806646109498
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35309,-0.254286242371925,0.119131053890941,-0.48778310799817,-0.0207893767456798,0.0328408402053232
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,37079,-0.0288437708209106,0.0621735044857806,-0.150703839613041,0.0930162979712193,0.642715120014799
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,37079,0.0330650041592093,0.0459124850659079,-0.0569234665699701,0.123053474888389,0.471438866685061
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,37079,-0.0139103623830858,0.0543737264816125,-0.120482866287046,0.0926621415208747,0.798089747822472
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,37079,0.0175257776763418,0.0787718783574608,-0.136867103904281,0.171918659256965,0.82393997389188
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35300,0.013177075502897,0.0675046488273443,-0.119132036198698,0.145486187204492,0.845240926092581
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X29153.Pain or discomfort today,35312,-0.032229441634405,0.0609684117715734,-0.151727528706689,0.0872686454378788,0.597084628879221
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29154.Anxiety or depression today,35312,-0.0646095667400709,0.0793321680556137,-0.220100616129074,0.090881482648932,0.415437092106765
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29166.Frequency of confiding in someone close,35128,-0.073271781423498,0.0599489998161249,-0.190771821063103,0.0442282582161069,0.221667251759909
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35292,-0.0313581834926936,0.011063826609278,-0.0530432836468785,-0.00967308333850862,0.00460774433059217
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35292,0.0166450910439359,0.0113264874845793,-0.00555482442583949,0.0388450065137114,0.141729243860558
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35292,0.0171649295333342,0.0141898959023014,-0.0106472664351766,0.044977125501845,0.226456816641717
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35292,0.00222794137782843,0.0131265808583906,-0.0235001571046171,0.0279560398602739,0.865230098508059
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35292,-0.00258676716332657,0.0224744777667442,-0.0466367435861451,0.041463209259492,0.908371244539735
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35292,0.0198406004657867,0.0107017604216851,-0.00113484996071604,0.0408160508922895,0.0637936094165421
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35291,-0.000609822021387155,0.0114981831681623,-0.0231462610309853,0.021926616988211,0.957704658331796
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35291,0.00833893962866329,0.0176724373411683,-0.0262990375600266,0.0429769168173532,0.637042663682951
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35291,-0.011840371906495,0.0257208782721704,-0.062253293319949,0.0385725495069589,0.645287974727673
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35291,0.0108091441484009,0.0205271109834787,-0.0294239933792173,0.0510422816760192,0.598505181991606
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35291,-0.0342091387031772,0.0345292076709255,-0.101886385738191,0.0334681083318367,0.321856516266482
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35291,0.00160074616056817,0.0156080901033741,-0.0289911104420451,0.0321926027631814,0.918316558208192
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29171.Frequency of feeling 'in tune' with people,35188,0.0061301097957024,0.0780853645642113,-0.146917204750152,0.159177424341556,0.93742878809226
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29172.Freuency of feeling that lacks companionship,35273,0.0590825373735109,0.0700733456130057,-0.0782612200279803,0.196426294775002,0.399176172838937
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29173.Frequency of feeling left out,35230,-0.00496288065406057,0.0747402363303275,-0.151453743861502,0.141527982553381,0.947060196025842
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29174.Frequency of feeling isolated from others,35263,-0.0925154145997518,0.0771334706478433,-0.243697017069525,0.0586661878700211,0.230411570546097
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29175.Tendency to bounce back quickly after hard times,35307,0.076360985864403,0.0614358907554347,-0.044053360016249,0.196775331745055,0.213938479829374
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29176.Ability to make it through stressful events,35307,0.00113634826407481,0.0586579942844443,-0.113833320533436,0.116106017061586,0.984544631392892
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29177.Quick recovery from stressful events,35307,-0.0371584407447278,0.0605987428329894,-0.155931976697387,0.0816150952079314,0.539774657027796
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29178.Hard to snap back when something bad happens,35307,0.0848891936077596,0.0587434849372763,-0.0302480368693019,0.200026424084821,0.14848594121861
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29179.Comes through difficult times with little trouble,35307,-0.0179119157833646,0.060462743903883,-0.136418893834975,0.100595062268246,0.767051409062336
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29180.Tendency to take a long time to get over setbacks,35307,0.09617569276154,0.0595295804569355,-0.0205022849340536,0.212853670457134,0.10623353476928
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29181.General happiness,35276,0.0489813309336269,0.0622195057366,-0.0729689003101091,0.170931562177363,0.431175399804263
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29182.Belief that own life is meaningful,35185,0.0154167384048696,0.0619724854855884,-0.106049333146884,0.136882809956623,0.803549187031138
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,35652,-0.0834395821807644,0.0555943966775525,-0.192404599668767,0.0255254353072386,0.133439844236916
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2946.Father's age,30176,-0.0309578692156483,0.0239436842183605,-0.0778874902836348,0.0159717518523382,0.19633414567511
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2966.Age high blood pressure diagnosed,36892,0.00921077419133154,0.00525563596093003,-0.00109027229209132,0.0195118206747544,0.0797187811320637
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30000.White blood cell (leukocyte) count,51830,-0.0407399204377495,0.0029419393252391,-0.0465061215152181,-0.0349737193602808,1.96770143417292e-43
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51831,0.0213215830914501,0.00311016484015933,0.0152256600047378,0.0274175061781623,7.29156163179309e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30020.Haemoglobin concentration,51831,0.0191683070975098,0.00333993216230533,0.0126220400593914,0.0257145741356283,9.63788930989613e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30030.Haematocrit percentage,51831,0.018608010873202,0.00325015710571678,0.0122377029459972,0.0249783188004069,1.04578619666341e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30040.Mean corpuscular volume,51831,-0.00909906333675873,0.00284974753460974,-0.0146845685045938,-0.00351355816892364,0.00141026442160439
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51831,-0.00876286345722951,0.00285997608488342,-0.014368416583601,-0.00315731033085799,0.00218681991437453
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51831,0.000236519010031727,0.00279954838549094,-0.00525059582553051,0.00572363384559396,0.932671812782548
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51831,-0.0142653292204298,0.00288696531121258,-0.0199237812304065,-0.00860687721045315,7.81616208494794e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30080.Platelet count,51831,-0.0243233392845321,0.00282650858989292,-0.0298632961207222,-0.018783382448342,8.08944133595987e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30090.Platelet crit,51831,-0.0198637765845834,0.00287852039811351,-0.0255056765648859,-0.0142218766042809,5.31163842860518e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51831,0.0147315713944757,0.00269567074024894,0.00944805674358782,0.0200150860453637,4.68052703304533e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30110.Platelet distribution width,51831,0.015042797479695,0.00280187591235511,0.00955112069147899,0.020534474267911,8.00288597678318e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30120.Lymphocyte count,51791,-0.0199037300457217,0.0027741279747765,-0.0253410208762837,-0.0144664392151598,7.46645794794594e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30130.Monocyte count,51791,-0.0118059997740664,0.00283937286956586,-0.0173711705984154,-0.00624082894971727,3.22285601658668e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30140.Neutrophill count,51791,-0.0390161245649212,0.00291048372982079,-0.0447206726753699,-0.0333115764544724,8.05556199285385e-41
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30150.Eosinophill count,51791,0.0155053676908859,0.00278511339230481,0.0100465454419684,0.0209641899398033,2.6176008558017e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30160.Basophill count,51791,-0.155022409327793,0.0333967697580532,-0.220480078053578,-0.0895647406020091,3.4726269678097e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30170.Nucleated red blood cell count,51791,0.224955919436948,0.167407251849771,-0.103162294188604,0.5530741330625,0.179038050490084
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30180.Lymphocyte percentage,51792,0.00805936841555647,0.00277022198325935,0.00262973332836815,0.0134890035027448,0.00362608202437947
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30190.Monocyte percentage,51792,0.0159594560041201,0.00280457187480254,0.0104624951295071,0.0214564168787331,1.28224458681353e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30200.Neutrophill percentage,51792,-0.0162768261616419,0.00274673973204604,-0.0216604360364521,-0.0108932162868316,3.1514998311188e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30210.Eosinophill percentage,51792,0.0287399316601914,0.00275765194484046,0.0233349338483041,0.0341449294720787,2.2491754652703e-25
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30220.Basophill percentage,51792,-0.00183665772507087,0.00275801868697711,-0.00724237435154601,0.00356905890140427,0.505460244864575
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30230.Nucleated red blood cell percentage,51791,0.226245615493419,0.167400439455771,-0.101859245839892,0.55435047682673,0.176541350607822
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30240.Reticulocyte percentage,51442,-0.00424394085969394,0.00298323012266204,-0.0100910719001115,0.00160319018072365,0.154866389214974
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30250.Reticulocyte count,51442,0.000512694086408305,0.00303675562941904,-0.00543934694725302,0.00646473512006963,0.865932249204548
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30260.Mean reticulocyte volume,51442,-0.0155361415523548,0.00278884712009596,-0.0210022819077429,-0.0100700011969668,2.56488389667486e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30270.Mean sphered cell volume,51442,-0.0141334071853788,0.00282493805998508,-0.0196702857829495,-0.00859652858780799,5.68496408316542e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30280.Immature reticulocyte fraction,51442,-0.0118896121670719,0.00294267671745653,-0.0176572585332867,-0.00612196580085707,5.35376627035327e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30290.High light scatter reticulocyte percentage,51442,-0.00837663138620052,0.00303928907904729,-0.0143336379811332,-0.00241962479126784,0.00585399787141006
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30300.High light scatter reticulocyte count,51442,-0.00451152461119011,0.00308068008932886,-0.0105496575862747,0.00152660836389446,0.143083156791028
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30500.Microalbumin in urine,37251,8.94969172422544e-05,0.00474650929889519,-0.00921366130859232,0.00939265514307682,0.984956995351828
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51819,0.0241380017924343,0.00308517895209703,0.0180910510463241,0.0301849525385445,5.34618527605975e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30520.Potassium in urine,51781,0.0220223131773556,0.00289406294521,0.016349949804744,0.0276946765499672,2.85951391975171e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30530.Sodium in urine,51761,0.0133442449201449,0.00304909258601592,0.00736802345155373,0.0193204663887361,1.21161294390407e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30600.Albumin,49570,-0.00942211173305755,0.00299888783520286,-0.0152999318900551,-0.00354429157605994,0.00168113682733977
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30610.Alkaline phosphatase,51410,0.0384852717991686,0.00293436048412058,0.0327339252502923,0.0442366183480449,3.75816408909702e-39
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30620.Alanine aminotransferase,51414,-0.00439277079615927,0.00313662981350118,-0.0105405652306216,0.00175502363830304,0.161385168544726
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30630.Apolipoprotein A,49423,0.00285768829370973,0.00329048962615558,-0.00359167137355521,0.00930704796097467,0.385147929030029
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30640.Apolipoprotein B,51306,0.0196496023455717,0.00273629544609233,0.0142864632712308,0.0250127414199127,7.13441782228292e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30650.Aspartate aminotransferase,51348,0.00606403391957484,0.00299729120455853,0.000189343158640122,0.0119387246805095,0.0430674614162789
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30660.Direct bilirubin,48160,0.0134335283026417,0.00318745252994043,0.00718612134395849,0.019680935261325,2.51486761174997e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30670.Urea,51397,0.0165596121489377,0.00289387720891916,0.0108876128194562,0.0222316114784193,1.06448782023394e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30680.Calcium,49573,-0.0144116111959568,0.00290427136128389,-0.0201039830640732,-0.00871923932784035,7.02564038241739e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30690.Cholesterol,51416,0.02481666539731,0.00275896712880038,0.0194090898248612,0.0302242409697587,2.54905781066657e-19
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30700.Creatinine,51407,0.0105865942065845,0.00321455938987985,0.00428605780242004,0.016887130610749,0.000991640676474689
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30710.C-reactive protein,51352,0.00148823984440403,0.00314035787794891,-0.00466686159637584,0.0076433412851839,0.635570382656481
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30720.Cystatin C,51423,0.0343956072329823,0.00317978779200553,0.0281632231606514,0.0406279913053131,3.34463855974702e-27
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30730.Gamma glutamyltransferase,51410,-0.0165030656598795,0.00315676745693119,-0.0226903298754646,-0.0103158014442943,1.7305593113252e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30740.Glucose,49555,-0.0114065897277888,0.0029782827964285,-0.0172440240087887,-0.00556915544678896,0.000128568273335489
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),51369,-0.0371718690535767,0.00301416933627573,-0.0430796409526771,-0.0312640971544763,7.88715746344346e-35
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30760.HDL cholesterol,49562,0.000223213586389833,0.00337244245395357,-0.00638677362335916,0.00683320079613883,0.947229185965992
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30770.IGF-1,51286,-0.033432436887694,0.00287192787428882,-0.0390614155213001,-0.027803458254088,3.14187199884494e-31
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30780.LDL direct,51365,0.0235654392456497,0.00270271594528374,0.0182681159928936,0.0288627624984058,2.99586284043116e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30790.Lipoprotein A,46913,-0.00380396944417344,0.00309592282353351,-0.00987197817829913,0.00226403928995225,0.219199525596584
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30810.Phosphate,49533,0.000940367057382783,0.00311186791777468,-0.0051588940614556,0.00703962817622116,0.762512352135116
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30830.SHBG,49399,-0.0104697205179485,0.0036088655116012,-0.0175430969206869,-0.00339634411521019,0.00372242999898141
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30840.Total bilirubin,51325,0.0254272901833701,0.00303071545846153,0.0194870878847855,0.0313674924819547,5.1547486010572e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30850.Testosterone,48821,-0.0277555117275897,0.00477229758627576,-0.0371092149966902,-0.0184018084584892,6.1221438494687e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30860.Total protein,49554,-0.0272948333506618,0.00291213749653116,-0.0330026228438629,-0.0215870438574607,7.7811913500981e-21
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30870.Triglycerides,51401,0.0227040842590953,0.00315464258464342,0.0165209847931942,0.0288871837249964,6.34916422832569e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30880.Urate,51381,0.0100434583029733,0.0033910841790938,0.00339693331194941,0.0166899832939971,0.00306245101501923
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30890.Vitamin D,50285,-0.00467592794098906,0.00320757560356681,-0.01096277612398,0.00161092024200189,0.144917081021108
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X3137.Number of measurements made,49938,0.00119395745273078,0.0394873116941884,-0.0762011734678786,0.0785890883733401,0.975878743007919
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X3143.Ankle spacing width,42392,0.0175032418649861,0.00477324236206564,0.00814768683533743,0.0268587968946348,0.000246424727812196
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",42391,-0.0103616793191037,0.00371814543511962,-0.0176492443719382,-0.00307411426626924,0.00533095015536605
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X3146.Speed of sound through heel,42392,-0.0130993690830504,0.0035608888769526,-0.0200787112818775,-0.0061200268842233,0.000235376579973634
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",42392,-0.0126067032271367,0.00360484082588545,-0.0196721912458722,-0.00554121520840122,0.000471787203902924
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X3148.Heel bone mineral density (BMD),42380,-0.0130782459458948,0.00361089796031582,-0.0201556059481138,-0.00600088594367579,0.000293565305133439
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X3526.Mother's age at death,48540,0.0101030313167991,0.00291852748395382,0.00438271744824963,0.0158233451853486,0.000537958327011865
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X3581.Age at menopause (last menstrual period),38580,0.00995428687779075,0.00400901563900902,0.00209661622533307,0.0178119575302484,0.01304634602983
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32849,-0.00398077481532484,0.00604142235489967,-0.0158219626309282,0.00786041300027852,0.509992816211626
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4100.Ankle spacing width (left),36838,0.0169331527533926,0.00659423350073486,0.00400845509195229,0.0298578504148329,0.0102513022123278
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4101.Heel broadband ultrasound attenuation (left),36835,-0.00971858773864395,0.0051172855435711,-0.0197484674040433,0.000311291926755405,0.0575799457502461
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4103.Speed of sound through heel (left),36838,-0.0109742647692165,0.00489292101518832,-0.0205643899589856,-0.00138413957944743,0.0249326952877655
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",36838,-0.0114973383841519,0.00495817557582789,-0.0212153625127745,-0.00177931425552923,0.020428610179858
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4105.Heel bone mineral density (BMD) (left),36833,-0.010950992581628,0.00495732133438632,-0.0206673423970252,-0.00123464276623085,0.0272004242777213
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",36838,-0.0114918848717909,0.00495816386410491,-0.0212098860454365,-0.00177388369814527,0.0204880793686091
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4119.Ankle spacing width (right),36839,0.0139172064295786,0.00651758926769221,0.00114273146490191,0.0266916813942554,0.032765724292609
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4120.Heel broadband ultrasound attenuation (right),36838,-0.00927896401890343,0.00512221454069282,-0.0193185045186613,0.000760576480854491,0.0701005343696968
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4122.Speed of sound through heel (right),36839,-0.0113199333695428,0.00489139102435842,-0.0209070597772853,-0.00173280696180032,0.0206800315039307
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",36839,-0.0112205229455772,0.00495842093870003,-0.0209390279854292,-0.0015020179057251,0.0236683900180842
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4124.Heel bone mineral density (BMD) (right),36834,-0.0113686592689862,0.00495601166761684,-0.0210824421375152,-0.00165487640045718,0.0218225102221002
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",36839,-0.0112188050932111,0.00495841988834219,-0.0209373080743618,-0.00150030211206036,0.0236897397368722
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4194.Pulse rate,37195,-0.0267620317993067,0.00468642379732945,-0.0359474224420724,-0.017576641156541,1.16643710351454e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4195.Pulse wave reflection index,37195,0.0126497660547014,0.00507522164563224,0.00270233162926219,0.0225972004801406,0.0127063803147101
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4196.Pulse wave peak to peak time,37189,0.0055104766761725,0.00464570811989597,-0.00359511123882361,0.0146160645911686,0.235600866587794
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4198.Position of the pulse wave peak,37195,-0.00829235848023939,0.00496411487226104,-0.018022023629871,0.00143730666939225,0.0948673746973778
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4199.Position of pulse wave notch,37195,-0.0132758483494902,0.00474521269493531,-0.0225764652315634,-0.00397523146741702,0.00515853011006354
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4200.Position of the shoulder on the pulse waveform,37195,-0.0122300942024469,0.00488605711228144,-0.0218067661425186,-0.00265342226237531,0.012332240520736
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4269.Number of triplets attempted (left),37002,0.16387732535146,0.145570797488031,-0.12144143772508,0.449196088428,0.260303107703492
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4270.Volume level set by participant (left),36908,-0.0805181746901794,0.049631315371589,-0.177795552818494,0.016759203438135,0.104774439633266
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4276.Number of triplets attempted (right),36999,0.0869577118858995,0.143040690212156,-0.193402040929927,0.367317464701726,0.543256325047829
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4277.Volume level set by participant (right),36903,-0.0871178164313816,0.0497638677189752,-0.184654997160573,0.0104193642978099,0.0800505057466207
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X4288.Time to answer,37197,-0.0113520106809956,0.00554271941747853,-0.0222157407392536,-0.000488280622737723,0.0405833459007812
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X4290.Duration screen displayed,37197,-0.0134524468513353,0.00522771010869288,-0.0236987586643733,-0.00320613503829723,0.0100913347592204
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X46.Hand grip strength (left),52437,0.0146008975701084,0.00396763241887114,0.00682433802912095,0.0223774571110958,0.000233758452342986
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X47.Hand grip strength (right),52463,0.0117493170639078,0.00393474285640802,0.00403722106534812,0.0194614130624676,0.00282905658274108
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X48.Waist circumference,52528,-0.0283870473535154,0.00601306005303157,-0.0401726450574572,-0.0166014496495735,2.36167814450764e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X4803.Tinnitus,37099,-0.0548496898411603,0.055906206564055,-0.164425854706708,0.0547264750243874,0.326572491634346
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X4825.Noisy workplace,37179,-0.0452376604432151,0.0645410201743864,-0.171738059985013,0.0812627390985823,0.483377543023883
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X4836.Loud music exposure frequency,37133,-0.044198091279773,0.107482671749047,-0.254864127907905,0.166467945348359,0.680928691052962
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X49.Hip circumference,52523,0.0275925670030887,0.00489875968457976,0.0179909980213124,0.037194135984865,1.79596301958896e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X50.Standing height,52503,0.0379088433932867,0.0038870038858722,0.0302903157769772,0.0455273710095962,1.98248202769857e-22
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X5057.Number of older siblings,35948,-0.0273084459164023,0.0538300921762394,-0.132815426581832,0.078198534749027,0.61195516831469
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X51.Seated height,52409,0.031455284405196,0.00363259161557889,0.0243354048386613,0.0385751639717306,5.05547829999199e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5181.Ever had eye surgery,34566,0.0180550398738632,0.109833798216813,-0.197219204631091,0.233329284378817,0.86943417955816
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5186.Duration visual-acuity screen displayed (right),34551,-0.00413977032717109,0.00570669796847239,-0.015324898345377,0.0070453576910348,0.468224215081042
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5188.Duration visual-acuity screen displayed (left),34551,-0.00198235369228727,0.0058648259924059,-0.0134774126374028,0.0095127052528283,0.735370970820077
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5190.Duration at which refractometer first shown (right),34477,-0.00196946314821123,0.00602430342929115,-0.0137770978696219,0.00983817157319941,0.743741612515495
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5193.Duration at which refractometer first shown (left),34476,-0.00429705369884559,0.00607021602636164,-0.0161946771105144,0.00760056971282323,0.479043937222874
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5199.logMAR, initial (right)",34534,-0.010539657179521,0.0635903643957742,-0.135176771395239,0.114097457036196,0.868365487696141
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5200.Final number of letters displayed (right),34534,0.476896424257788,0.362898445164644,-0.234384528264914,1.18817737678049,0.188858286746125
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5201.logMAR, final (right)",34475,-0.00370720949984989,0.00630572160985451,-0.0160664238551647,0.00865200485546494,0.556616489453632
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5202.Number of rounds to result (right),34534,0.0128292313944476,0.0586883226250388,-0.102199880950628,0.127858343739524,0.826970500597301
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5206.logMAR, initial (left)",34531,0.019393147340018,0.0638787672337739,-0.105809236438179,0.144595531118215,0.761449812588117
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5207.Final number of letters displayed (left),34531,0.0878528643994156,0.334202642050582,-0.567184314019725,0.742890042818557,0.792658587557989
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5208.logMAR, final (left)",34469,-0.00770751115086512,0.0062661758280216,-0.0199892157737875,0.00457419347205722,0.218745092207292
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5209.Number of rounds to result (left),34529,0.0731142553525765,0.0589531276099131,-0.0424338747628531,0.188662385468006,0.21495240455758
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",34274,0.00366907769290488,0.00588429229852432,-0.00786413521220278,0.0152022905980125,0.532959274675352
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",34274,-0.00373193442308799,0.00594456634682034,-0.0153832844628559,0.00791941561667988,0.530170274576168
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5256.Corneal hysteresis (right),34274,-0.00943381856460925,0.00592359791490385,-0.0210440704778208,0.00217643334860231,0.111316090984336
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5257.Corneal resistance factor (right),34274,-0.00988279639982203,0.00598108686263796,-0.0216057266505924,0.00184013385094836,0.0985268087133292
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",34267,-0.00975547206667854,0.00584346331789493,-0.0212086601697526,0.00169771603639553,0.0950864664610708
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",34267,-0.0131499931319706,0.00589325758043818,-0.0247007779896294,-0.00159920827431175,0.0257006614192739
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5264.Corneal hysteresis (left),34267,-0.00351698492878114,0.00598845525765301,-0.015254357233781,0.00822038737621877,0.557032285135993
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5265.Corneal resistance factor (left),34267,-0.00909986134133032,0.00600853902637841,-0.020876597833032,0.00267687515037138,0.129964368064475
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34673,-0.514727823931168,0.329235358800646,-1.16002912718043,0.130573479318097,0.118015400855981
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52464,-0.015068889378768,0.0146736535085753,-0.0438292502555757,0.0136914714980396,0.304461714134284
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52464,-0.0227644339997132,0.0156172458969192,-0.0533742359576748,0.00784536795824847,0.144951320542399
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52464,0.0547959003691891,0.0415544660376586,-0.0266508530646218,0.136242653803,0.187298292305436
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52464,-0.0317503147409418,0.00632230363436441,-0.0441420298642961,-0.0193585996175876,5.15265139850379e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52464,0.0281996732303299,0.00595219515755109,0.0165333707215298,0.0398659757391301,2.17440496796191e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38398,0.00564791030122374,0.008642788866914,-0.0112919558779277,0.0225877764803752,0.513461664719972
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38398,-0.0297190756071411,0.0184631218380686,-0.0659067944097556,0.00646864319547343,0.10750962675302
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38398,-0.020631428903257,0.0228031704487975,-0.0653256429829001,0.0240627851763861,0.365615475168884
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38398,0.00216205540389364,0.0122926449796325,-0.021931528756186,0.0262556395639733,0.860390489306315
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52539,0.00854317274853184,0.0123861728331498,-0.0157337260044417,0.0328200715015054,0.49036791910827
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52539,0.00854317274853184,0.0123861728331498,-0.0157337260044417,0.0328200715015054,0.49036791910827
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52539,0.00739934708861967,0.00990426840504599,-0.0120130189852705,0.0268117131625098,0.455018758835215
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52539,0.0399923973066603,0.0171427424784725,0.00639262204885417,0.0735921725644663,0.0196615583268553
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52539,-0.0112534859913532,0.0410447771396872,-0.0917012491851402,0.0691942772024338,0.783951924561839
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52539,0.0368844181042873,0.0278816040812586,-0.0177635258949796,0.0915323621035542,0.185883453197126
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52539,-0.0126502110794225,0.0463753456994183,-0.103545888650282,0.0782454664914373,0.785025670793945
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52464,-0.00818980868261199,0.00915039665620034,-0.0261245861287646,0.00974496876354068,0.370784446928743
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52464,-0.0167009214528973,0.0154264067491523,-0.0469366786812359,0.0135348357754412,0.278988776706791
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52464,0.00735924320539224,0.00915979720965471,-0.010593959325531,0.0253124457363155,0.42173524654161
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52464,-0.0215564908845879,0.0129246259354426,-0.0468887577180553,0.00377577594887961,0.0953566039159124
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52464,0.00187450000973453,0.0156964123286319,-0.028890468154384,0.032639468173853,0.904941909173256
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52464,-0.0104707613231807,0.00612284794542483,-0.0224715432962134,0.00153002064985194,0.0872583262762731
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,38982,-0.0136451409893253,0.014130376353709,-0.0413406786425948,0.0140503966639443,0.334238136662979
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,38982,-0.0378927894475412,0.0120811536608452,-0.0615718506227979,-0.0142137282722846,0.00171471956703875
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,38982,-0.0182879074484397,0.0174546943957184,-0.0524991084640477,0.0159232935671683,0.294786238935417
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,38982,0.0269783457826123,0.0136851507126977,0.00015545038572469,0.0538012411794998,0.0487109435351714
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52456,-0.00711568259291495,0.0209412692071168,-0.0481605702388638,0.0339292050530339,0.734015994491949
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52456,-0.010616160701988,0.0320014152425115,-0.0733389345773107,0.0521066131733346,0.740088317946183
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52456,0.00387558988913319,0.0505147579887377,-0.0951333357687927,0.102884515547059,0.938845415591177
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52456,0.0430969878708427,0.052937375694996,-0.0606602684913494,0.146854244233035,0.415588746020761
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52456,0.00778792540526209,0.0173717088327702,-0.0262606239069675,0.0418364747174917,0.65393305282885
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52456,-0.0112473704633371,0.024103350189421,-0.0584899368346022,0.0359951959079281,0.640768272044695
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52456,-0.000193629724285084,0.0126992405036015,-0.0250841411113439,0.0246968816627738,0.987834979504876
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",36100,0.0406977579949294,0.0168540876207426,0.00766374625827383,0.0737317697315849,0.0157735011468631
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",36100,-0.0505095407962691,0.0176358450379921,-0.0850757970707337,-0.0159432845218046,0.00419552935379861
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",36100,0.0322732934757721,0.0247713744158922,-0.0162786003793767,0.0808251873309208,0.192670680578001
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",36100,-0.0306150509568457,0.010307914098691,-0.0508185625902801,-0.0104115393234113,0.00298772801887163
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",40684,-0.0351995047295477,0.00820752841328347,-0.0512862604195833,-0.0191127490395121,1.81202544344274e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",40684,0.0376242620077195,0.00970368192374954,0.0186050454371704,0.0566434785782686,0.000106202321702858
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",40684,0.0144155684211278,0.00803472849337402,-0.00133249942588523,0.0301636362681409,0.0728143134662691
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",40684,-0.00124066783842676,0.01847303102574,-0.0374478086488772,0.0349664729720236,0.946454675104082
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",40684,-0.0276275930303528,0.0103037584105032,-0.0478229595149391,-0.00743222654576656,0.00734388105381526
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",40684,0.000888463247646372,0.0147449023183505,-0.0280115452963206,0.0297884717916133,0.951953094840446
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52464,-0.0142671552860277,0.0171160685933771,-0.0478146497290468,0.0192803391569914,0.404541312309562
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52464,-0.000543564433075174,0.0129477958093053,-0.0259212442193136,0.0248341153531633,0.966514018979239
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52464,0.047267720679149,0.0325771697883929,-0.0165835321061009,0.111118973464399,0.146808321700761
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52464,-0.0255970680827549,0.0120868223818223,-0.0492872399511266,-0.00190689621438328,0.0342054183393957
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52464,-0.00266547630118421,0.0142542601364531,-0.0306038261686322,0.0252728735662638,0.85166613245058
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52464,-0.071987789782039,0.0169941043406532,-0.105296234289719,-0.0386793452743586,2.28365491741254e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52464,0.0140383279327043,0.00572101570623966,0.00282513714847452,0.025251518716934,0.0141421492450334
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34965,-0.0361537048486339,0.0147059461887124,-0.0649773593785101,-0.00733005031875765,0.0139833191970759
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34965,-0.0342810734953258,0.0181075933749121,-0.0697719565101535,0.00120980951950184,0.0583828822981854
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34965,0.0372594371213183,0.0126383874286046,0.0124881977612533,0.0620306764813834,0.00320997887239346
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34965,-0.0101172233372389,0.0118744319441859,-0.0333911099478432,0.0131566632733654,0.394239750561443
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52564,-0.0101044152539811,0.00764278373679033,-0.0250842713780901,0.00487544087012797,0.18615254744552
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52564,-0.0354121306409182,0.0211804203759237,-0.0769257545777285,0.0061014932958922,0.0945519751920743
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52564,-0.00763549663842297,0.00636270992113843,-0.0201064080838543,0.00483541480700836,0.23013656739926
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52564,-0.00223662014540094,0.00612206141867307,-0.0142358605260002,0.00976262023519828,0.714862608684072
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52564,-0.0144753627649899,0.0104385181723626,-0.0349348583828206,0.00598413285284086,0.165538608495002
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52564,-0.00746120762368386,0.00782487368885171,-0.0227979600538332,0.0078755448064655,0.34033432524379
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52564,-0.00511455367182565,0.00639811726181174,-0.0176548635049767,0.00742575616132535,0.424075809675703
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52564,-0.0487897330503958,0.0196284853380299,-0.0872615643129344,-0.0103179017878572,0.0129380946248936
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,45813,0.015446589468824,0.00660524127669603,0.00250031656649977,0.0283928623711482,0.0193712912026543
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,45813,0.00984314030848847,0.00686639356626923,-0.00361499108139922,0.0233012716983762,0.151726943782395
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,45813,-0.00398862362435795,0.00727605491135912,-0.0182496912506218,0.0102724440019059,0.583572294367578
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,45813,-0.0160631920460399,0.00992105932841539,-0.0355084683297341,0.00338208423765426,0.105444617954997
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,45813,0.000731780122474913,0.00662898579163983,-0.0122610320291391,0.013724592274089,0.912100653108572
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,52327,-0.0168871315528431,0.00670933073649855,-0.0300374197963803,-0.00373684330930593,0.0118438582153965
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,52327,0.0160233226361716,0.00544201243961446,0.00535697825452724,0.0266896670178159,0.00323929994068116
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,52327,0.00568806563392675,0.00563177922338299,-0.0053502216439039,0.0167263529117574,0.312508523605478
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,52327,0.0586640292069715,0.0121942200376623,0.0347633579331534,0.0825647004807895,1.51269244477165e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),52346,0.0165675160620047,0.00604869861840247,0.00471206676993582,0.0284229653540735,0.00616694698243916
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,52346,0.0508724238253012,0.0119599697450018,0.0274308831250977,0.0743139645255047,2.1122606390419e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52464,-0.000335313836606844,0.00552760248191228,-0.0111694147011549,0.0104987870279412,0.951629144860293
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52464,0.00465589675822239,0.00633625180232359,-0.00776315677433185,0.0170749502907766,0.462466891691782
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52464,-0.00505328389880502,0.00959892349706867,-0.0238671739530596,0.0137606061554496,0.598585621426534
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52464,-0.00439719014369039,0.0132504234582588,-0.0303680201218775,0.0215736398344968,0.740003400337367
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52464,0.0306935247609165,0.0167382999113849,-0.00211354306539794,0.0635005925872309,0.0667068289108944
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52464,-0.00716175356406025,0.0158754045074363,-0.0382775463986355,0.023954039270515,0.651905402530628
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",42392,-0.0126080092115566,0.00360482579552524,-0.0196734677707861,-0.00554255065232712,0.00047112173548724
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X864.Number of days or week walked 10+ minutes,51967,0.0563290667280263,0.030172090185849,-0.00280823003623779,0.11546636349229,0.0619247324625772
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X874.Duration of walks,48831,0.00825270478434801,0.00301426145060085,0.00234475234117034,0.0141606572275257,0.00618911629102842
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,51006,0.069365496088243,0.0290039715243638,0.0125177119004898,0.126213280275996,0.0167841681797886
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X894.Duration of moderate activity,46081,0.0745123343790549,0.035951177706174,0.00404802607495391,0.144976642683156,0.0382248554530796
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X90087.No-wear time bias adjusted average acceleration,33508,0.0167464987264076,0.00707414892361999,0.00288116683611239,0.0306118306167028,0.0179632061163294
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50917,0.120717549262998,0.0301685101572885,0.0615872693547126,0.179847829171283,6.31663591297575e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X914.Duration of vigorous activity,40499,0.00693860689216616,0.00371843191312504,-0.000349519657558924,0.0142267334418912,0.062066754615996
